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IL-17 produced by group 3 innate lymphoid cells (ILC3) and γδT cells is pivotal for host 
defense against epicutaneous candidiasis via neutrophil activation
MT Iwasawa,1 Y Nakamura,1 S Wakabayashi,1 S Saijo2 and H Matsue1 1 Dermatology, 
Chiba University, Chiba, Japan and 2 Medical Mycology Research Canter, Chiba University, 
Chiba, Japan
IL-17 reportedly played a key role in mouse systemic candidiasis in C-type lectin (i.e., Dectin-1 and 
-2)-dependent manner. However, defense mechanisms against epicutaneous infection of Candida 
albicans, termed epicutaneous candidiasis (ECC) remain to be clarified. Here, we developed ECC 
mouse model, in which C. albicans was inoculated occlusively on shaved skin for 7 days. In this 
model, skin inflammation reached a peak on day 2 with neutrophil infiltration and subsided by day 
7 in WT, Il17a-/- and Il17f-/- mice, while Il17a-/--Il17f-/- mice showed more severe inflamed skin even 
on day 7 with the high fungal burden, indicating the importance of IL-17 for ECC defense. When ana-
lyzed in Clec7a-/--Clec4n-/- (Dectin-1-and-2-deficient), Tlr2-/-, Myd88-/-,Fcer1g-/- and Card9-/- mice, 
none of these receptors or molecules was involved in ECC, suggesting the unknown mechanism of C. 
albicans recognition, contrary to the systemic infection. We next sought to identify IL-17-producing 
cells by flow cytometry. IL-17A and -F were produced by CD90+ ILC3 and γδT cells, but not by 
αβT cells only in infected skin but not in uninfected control. To confirm a role of ILC3 in ECC, we 
tested Rag2-/- (T and B cell-deficient) and Rag2-/--Il2rg-/- (T, B cell and ILCs-deficient) mice. Albeit 
Rag2-/- mice cleared C. albicans, Rag2-/--Il2rg-/- mice failed to clear this fungus. Taken together, ILC3 
was sufficient to ECC defense, although it is still unclear how much γδT cells contribute to ECC 
immunity. In addition, we detected lower mRNA expression of antimicrobial peptides (AMPs) and 
less number of neutrophils in the infected skin from Il17a-/--Il17f-/- mice than in that of WT mice. 
Neutrophils isolated from Il17a-/--Il17f-/- mice had less killing activity against C. albicans than those 
from WT mice in vitro. In conclusion, IL-17 from ILC3 and γδT cells plays a pivotal role on host 
defense against ECC by recruiting neutrophils, which release AMPs to clear C. albicans.    
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Individual naïve T cells give rise to both TRM and TCM after 3 different skin immunizations
O Gaide,1 RO Emerson,2 X Jiang,3 H Robins,2 R Clark3 and TS Kupper3 1 Dermatology, 
CHUV, Lausanne, Switzerland, 2 Adaptive Biotech, Seattle, WA and 3 Dermatology, Brigham 
and Women’s Hospital, Boston, MA
The generation of memory T cells is incompletely understood. There are different hypotheses regard-
ing the fate of neo-activated naïve T cell. Current models propose variation of the “one cell-one fate” 
model holding that a naive T cell can become a specific T cell subtype (for example a central memory 
T cell (TCM) or an effector memory T cell (TEM), but not both. The difference is how this process is 
achieved, proposing it to be stochastic, dictated by TCR affinity, or influenced by micro-environ-
mental factors. Our recent work has focused on skin immunization generating both TCM and TRM 
cells, which could also be governed by the mechanisms described above. To test this hypothesis, 
we have used high throughput TCR sequencing (HTS) to track daughter cells of sensitizer-activated 
naive T cell. After 3 distinct antigenic challenges (a protein, a chemical hapten and a poxvirus), we 
selected skin TRM clones (with unique Vb CDR3 sequences) that were undetectable in skin or LN 
prior to antigen exposure, but abundant in skin (>5 copies/400ng gDNA) at >30 days after antigen 
encounter. For all three challenges, we found clones with identical CDR3’s in antigen-treated skin 
and distant skin (as expected for TRM), but also draining and distant LN (thus defining these cells as 
TCM). This was not a function of peripheral blood contamination, as in a parallel experiment only one 
of the top ten clones found in blood was also found in skin and LN. The mean TRM clone size was 
18 cells/400ng gDNA and the mean TCM clone size was 16 cells/400ng gDNA. Hence, we provide 
strong in vivo evidence that a single naive T cell can have more than one memory lineage fate.   
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Commensal microbe-derived short chain fatty acids induce cutaneous regulatory T cells 
in mice
A Schwarz, A Bruhs and T Schwarz Dermatology, University Clinic Kiel, Kiel, Germany
There is solid evidence that gut commensal microbes affect the mucosal immune system via expan-
sion of regulatory T cells (Treg) in the colon. Treg are able to suppress immune and inflammatory 
reactions mostly via production of interleukin 10, which appears crucial for controlling inflammatory 
reactions. A well characterized subset of Treg is the CD4+CD25+ population which expresses the 
transcription factor Foxp3. Commensal microbes induce Treg in the colon via short chain fatty acids 
(SCFA). SCFA which include butyrate, propionate and acetate are bacterial metabolites generated 
during fermentation. The effects of SCFA are dependent on the G protein-coupled receptors 41 and 
43. Thus, we postulated that SCFA produced by commensal skin bacteria under microaerophilic 
conditions (S.epidermidis) may also activate resident skin Treg that are diminished in certain inflam-
matory dermatoses. To address this issue, sodium butyrate was injected subcutaneously into the ear 
of hapten-sensitized mice. After 24 hours the same ear was challenged and ear swelling measured. 
Mice, which were injected with sodium butyrate before challenge, responded with a significantly 
reduced CHS reaction when compared to the positive controls. RNA was isolated from ears and 
the transcription of foxp3 and il-10 was determined by quantitative real time PCR. The expression 
of both genes was upregulated upon treatment with sodium butyrate, suggesting that skin Treg were 
activated. Furthermore, immunofluorescence analysis of ear tissue revealed also the presence of 
enhanced numbers of Foxp3-positive cells in sodium butyrate injected ears. Finally, we examined 
the expression of GPR43 on T cells isolated from the skin. FACS analysis revealed that Treg as well 
CD4+CD25- obtained from murine skin express this receptor. Incubation of CD4+CD25- cells with 
sodium butyrate significantly upregulated the expression of GPR43. This indicates that skin Treg 
can be activated by SCFA and that this represents a new area of study for biological function of 
skin microbiota in treatment of cutaneous immune responses so far only described in gut disorders.   
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Langerhans cells migrate to lymph nodes with increased number in mice with Stat3 activation 
in keratinocytes and are essential for development of psoriasis-like lesion
K Nakajima,2 S Kataoka,2 M Yamamoto,2 B Malissen1 and S Sano2 1 Centre d’Immunologie 
de Marseille-Luminy, UM2 Aix-Marseille Université, Marseille, France and 2 Department of 
Dermatology, Kochi Medical School, Nankoku, Japan
Psoriasis is an inflammatory disease with the underlying aberrant crosstalk of epidermis and immune 
system. However, the role for Langerhans cells (LCs) in psoriasis largely remains unclear. To exam-
ine whether LCs are involved in the development of psoriasis, we took an advantage in K5.Stat3C 
transgenic mice, which are induced to generate psoriasis-like lesion by topical treatment with 
12-O-tetradecanoylphorbol-13-acetate (TPA), whereby keratinocyte Stat3 was further activated. 
Compared with nontransgenic mice, K5.Stat3C mice with no treatment constitutively showed an 
increased number of langerin (+) cells in the skin-draining lymph nodes (SdLN), suggesting LCs with 
a tendency of emigration from the epidermis where Stat3-activated keratinocytes predominated. 
Topical TPA treatment of K5.Stat3C mice resulted in development of psoriasis-like lesion, when 
further enhanced LCs migration was noted. To study the function of LCs during psoriasogenesis, 
we crossed K5.Stat3C mice with langerin-diphtheria toxin (DT) receptor mice. Development of 
skin lesion in K5.Stat3C mice was remarkably inhibited in the absence of both LCs and langerin 
(+) dDCs. Importantly, skin lesion did not develop when LCs were still depleted but langerin (+) 
dDCs recovered, strongly suggested that LCs, not langerin (+) dDCs, were essential for the devel-
opment of psoriasis-like lesion. Not only IL-23 producing-LCs but also IL-23 producing other DC 
population were detected in SdLN cells from TPA treated-K5.Stat3C mice, implicating that they 
could differentiate and activate Th17 cells to shape psoriasiform phenotype. Collectively, our study 
indicates that Stat3 activation of keratinocytes lead to LCs activation in situ, and that their migration 
to SdLN is essential for psoriasogenesis, since they activate Th17 cells through stimulation with IL-23.   
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IκBζ plays an important role in the pathogenesis of psoriasis by mediating IL-17A-driven 
effects.
C Johansen,1 P Ommen,1 T Bertelsen,1 H Vinter,1 S Hailfinger,2 S Lorscheid,2 K Schulze-
Osthoff2 and L Iversen1 1 Department of Dermatology, Aarhus University Hospital, Aarhus, 
Denmark and 2 Department of Molecular Medicine, Eberhard Karls University, Tübingen, 
Germany
Psoriasis is a chronic immune-mediated skin disease characterized by epidermal hyperplasia and 
leukocyte infiltration. The molecular mechanisms underlying the pathogenesis of psoriasis are not 
fully understood. Recently NFKBIZ, a gene encoding the atypical IκB protein IκBζ, was identified 
as a new psoriasis susceptibility gene. Thus, the purpose of this study was to characterize the 
role of IκBζ in the pathogenesis of psoriasis. Using siRNA to knockdown IκBζ in cultured human 
keratinocytes we found that IκBζ was essential for TNFα/IL-17A-induced expression of a number of 
psoriasis-related proteins, including IL-8, IL-17C, IL-19, CCL20 and hBD2. ChIP analyses demon-
strated that IκBζ interacted directly with the promoters of these psoriasis-related proteins. Charac-
terization of the regulatory mechanisms involved in TNFα/IL-17A-induced expression revealed that 
in human keratinocytes IκBζ expression was mainly induced by IL-17A and only to a lesser extent 
by TNFα. Moreover, the IL-17A-induced expression of IκBζ was found to be mediated through a 
p38 MAPK-dependent mechanism and involved IκBζ gene transcription. The role of IκBζ in the 
pathogenesis of psoriasis was further investigated using an IL-23-induced psoriasis mouse model. We 
found that IL-23-induced psoriasis skin inflammation was completely absent in IκBζ-deficient mice 
compared with wild-type mice as measured by ear thickness and histological evaluation. In addition, 
IκBζ mRNA expression was demonstrated to be significantly increased in skin biopsies taken from 
lesional psoriatic skin compared with nonlesional psoriatic skin. Taken together, we here identify 
IκBζ as a vital protein for IL-17A-driven effects in psoriasis, and provide a new understanding of the 
mechanistic underpinnings in the pathogenesis of psoriasis. Moreover, our data suggest that targeting 
IκBζ may be a possible future strategy in the treatment of psoriasis and other IL-17A-driven diseases.   
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Opposing roles for Neurokinin-1 receptor in skin resident and circulating immune cells
Y Fritz, D Diaconu, M Camhi, TS McCormick and NL Ward Dermatology, Case Western 
Reserve University, Cleveland, OH
Substance P (SP) is increased in psoriasis plaque and in KC-Tie2 mouse skin and nerve cell bodies 
(DRGs). Axotomy of nerves at their entry point into the skin resolved psoriasiform skin inflammation 
in KC-Tie2 mice and introducing SP back into denervated skin returned the T and dendritic cell 
(DC) phenotype back to innervated conditions. Chemical inhibition of SP resulted in similar disease 
improvement. To elucidate the criticality of SP interactions with it’s receptor, neurokinin-1 (NK1R) 
in promoting skin inflammation in the KC-Tie2 mouse model of psoriasis, we backcrossed KC-Tie2 
to NK1R-deficient (-/-) mice. Adult KC-Tie2 x NK1R-/- mouse skin had 37% fewer CD11c+ DCs (n=6 
ea; P=0.04 vs. KC-Tie2); but no difference in acanthosis or CD4+ T cells was observed. NK1R-/- mice 
treated with topical Aldara for 5 days had significant decreases in skin CD4+ T cells and CD11c+ 
DCs (n=10 ea; P<0.05). Together these data suggest that SP-NK1R contribute to T cell and DC 
skin infiltration in a model-dependent manner. In both models, changes in T cell- and DC-derived 
cytokine levels were not detected, perhaps reflective of whole skin lysates containing a mixed cell 
population and a “dilution” effect from other cells, such as KCs. To explore the importance of skin 
resident- vs. bone marrow (BM)-derived immune cells, BM from WT or NK1R-/- donor mice was 
transplanted into KC-Tie2 and WT (n=3-8) recipients; transplanted WT mice were then treated 
with Aldara. Surprisingly, KC-Tie2 mice receiving NK1R-/- BM developed further increases in skin 
inflammation (vs. KC-Tie2 with WT BM), evidenced by ~3-4-fold increase in skin IL-17A/F, IFNγ, 
IL-12p35 (P<0.05), suggesting that NK1R+ circulating immune cells may suppress inflammation 
rather than promote it. Similar increases in inflammation were observed in WT mice receiving NK1R-
/- BM followed by Aldara. Collectively our data suggest opposing roles for NK1R in skin-resident 
vs. circulating immune cells, such that NK1R+ resident skin cells are pro-inflammatory, whereas 
BM-derived NK-1R+ cells appear to be suppressive.    
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Human skin harbours a resident T cell subset with rapid, innate-like responsiveness: a new 
perspective on tissue immune-surveillance
R Woolf, O Nussbaumer and A Hayday Department of Immunobiology, King’s College 
London, London, United Kingdom
The skin contains many tissue-resident immune cells that play key roles in skin homeostasis. We 
have shown that murine epidermal Vγ5+Vδ1+ T cells use receptors such as NKG2D to respond 
rapidly to tissue dysregulation, thereby contributing to barrier integrity and cutaneous atopy. We 
have described such biology under the term ‘lymphoid stress surveillance’. Here we have asked 
whether human skin likewise includes the potential for lymphoid stress surveillance. Protocols 
were established to isolate lymphocytes from normal adult human skin, which were characterized 
by flow cytometry, including functional responses following in vitro activation under different 
conditions. Applying a modified explant protocol distinct skin-resident lymphocyte subsets were 
identified, including γδ T cells [4.1% of CD3+ ± 1.1%] that predominantly expressed the Vδ1 TCR 
chain, as opposed to Vδ2+ peripheral blood T cells. Both CD8+ TCRαβ+ TRM cells and skin-resident 
γδ T cells had a ‘memory’ phenotype, expressed skin-homing markers and the activatory receptor 
NKG2D, but were predominantly CD28–. Skin-resident γδ T cells expressed granzyme B and upon 
in vitro activation with PMA and ionomycin, readily produced IFNγ and TNFα. Strikingly, however, 
TCRαβ+ TRM cells and Vδ1
+ T cells were distinct in that only Vδ1+ T cells activated upon exposure to 
recombinant ligands for the NKG2D receptor alone, independent of the TCR: a hallmark of innate-
like responsiveness. Such NKG2D-mediated activation was dependent upon PI3K and calcineurin 
activity. In addition, skin-derived Vδ1+ T cells killed transformed cellular targets in vitro, in part 
mediated by NKG2D, demonstrating the functional potential of these cells in tissue stress-surveil-
lance. These data provide the first clear identification of a human innate-like T cell subset, and 
places skin-resident Vδ1+ T cells in the afferent immune response. This strongly argues that the 
potential role of lymphoid stress surveillance should be considered in studies of skin infection, 
atopy, inflammation and malignancy.    
414
The pruritus- and TH2-associated cytokine interleukin-31 promotes growth of sensory nerves
M Feld,1 R Garcia,2 S Katayama,3 G Muirhead,4 O Sergeeva,5 S Tsoka,4 J Kere,3 S Dillon,2 
M Steinhoff6 and B Homey1 1 Dermatology, HHU, Düsseldorf, Germany, 2 ZymoGenetics, 
Seattle, WA, 3 Biosciences, Karolinska Institutet, Huddinge, Sweden, 4 Informatics, King`s 
College, London, United Kingdom, 5 Neurophysiology, HHU, Düsseldorf, Germany and 6 
Dermatology, UCD, Dublin, Ireland
Pruritus is a cardinal symptom of atopic dermatitis. Next to direct neuronal activation an increased 
cutaneous sensory network is thought to contribute to pruritus. Although the immune cell - IL-31 
- neuron axis has been implicated in severe pruritus during atopic skin inflammation, IL-31’s neuro-
poietic potential has not been evaluated, yet. To analyze the IL-31-related transcriptome in sensory 
neurons and to investigate whether IL-31 promotes sensory nerve fiber outgrowth in vitro and in 
vivo. During in vitro-analyses, primary sensory neuron culture systems were subjected to whole 
transcriptome sequencing, Ingenuity pathway analyses, immunofluorescence and nerve elongation 
as well as branching assays. In vivo, we investigated the cutaneous sensory neuronal network in 
wildtype, Il31-transgenic and IL-31-pump equipped mice. Both, transgenic Il31-overexpression and 
s.c. delivery of exogenous IL-31 induced a significant increase in the cutaneous nerve fiber density in 
lesional skin in vivo. Transcriptional profiling of IL-31-activated DRG neurons revealed enrichment 
for genes promoting nervous system development, neuronal outgrowth and negatively regulating 
cell death. The growth cones of primary small diameter DRG neurons showed abundant IL-31RA 
expression. Indeed, IL-31 selectively promoted nerve fiber extension only in small diameter neurons. 
STAT3 phosphorylation mediated IL-31-induced neuronal outgrowth and pharmacological STAT3 
inhibition completely abolished this effect. In contrast, active TRPV1 channels were dispensable 
for IL-31-induced neuronal sprouting. The pruritus- and TH2-associated cytokine IL-31 induces a 
distinct transcriptional program in sensory neurons leading to nerve elongation and branching in 
vitro and in vivo.    
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Comprehensive T cell repertoire mapping in naïve and antigen-experienced mice reveals 
unexpected T cell repartition
O Gaide,1 RO Emerson,2 X Jiang,3 H Robins,2 R Clark3 and TS Kupper3 1 Dermatology 
Venereology, CHUV, Lausanne, Switzerland, 2 Adaptive Biotech, Seattle, WA and 3 
Dermatology, Brigham and Women’s Hospital, Boston, MA
Next generation sequencing of TCR genes allows for T cell tracking at levels never seen before. 
Using this technique, we provide the first unbiased snapshot of the T cell repertoire in mice lymph 
node and skin. In 6 weeks-old mice there was only 1% overlap in unique sequences between 
cervical and inguinal lymph nodes. This overlap however corresponded to 5% of the total T cells, 
suggesting that small populations of expanded memory T cell clones were common to both LN. In 
the corresponding skin sites, the overlaps were 5% (unique) and 20% (total T cells) respectively. 
This is consistent with the fact that skin contains memory T cells undiluted by naive T cells. In 
comparison, littermates exposed to DNFB (and kept in SPF for 4 weeks) had a markedly different T 
cell repertoire. The overlap at the level of unique TCR sequences remained at 1%, but the overlap 
at the level of total T cells increased from 5% to 7% (p=0.031), indicating a small but appreciable 
increase in memory T cell clones. In the skin, the overlap at the unique sequence level increased 
from 5% to 11% (p= 0.04). More dramatically, the overlap at the % total T cells increased from 20% 
to 50% (p=0.0025). This strongly suggests that the skin of these mice harbor 30% of T cells deriving 
from common precursors presumably specific for DNFB-modified antigens. When examining clones 
present at > 5 cells in immunized skin, 2 clones were present prior to DNFB (avrg size 7.5) and 
24 clones after (avrg size 41). Of these 24 clones, 100% were also present at >5 T cells/sample in 
distant skin, 96% were present in the draining LN, and 71% in distant LN (thus identifying as TCM). 
Importantly, blood contamination was excluded by parallel sequencing of blood samples. These 
results indicate that naïve T cells represent the vast majority of LN cells, and that immunization 
induces both skin-resident T cell cells (TRM) and LN-resident T cells (TCM) bearing identical TCR.   
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Cutaneous OX40-OX40L signaling improves anti-microbial but impairs anti-tumoral immunity
KD Zielinski,1 G Geidel,1 W Hafezi,2 J Kühn,2 TA Luger1 and K Loser1 1 Dermatology, 
University of Münster, Münster, Germany and 2 Medical Microbiology, University of 
Münster, Münster, Germany
The skin is exposed to environmental factors resulting in the induction of immune responses. Previ-
ous work demonstrated that members of the TNF/TNF receptor family are involved in the regulation 
of cutaneous immunity. Signaling via the TNF receptor OX40 and its ligand OX40L is known to 
control T cell clonal expansion. To investigate the role of OX40/OX40L interactions during cutane-
ous infections and melanoma progression we generated transgenic mice overexpressing OX40 in 
basal keratinocytes (K14-OX40 tg). Upon epicutaneous infection with Herpes simplex virus type 1 
(HSV) tg mice developed significantly smaller skin lesions and showed a decreased virus replication 
as assessed by immunofluorescence staining and mRNA quantification of ICP27. Cytolytic CD8+ T 
cells were increased in infected skin and draining lymph nodes from tg mice compared to wt con-
trols pointing to an up-regulation of MHC class I-mediated anti-viral immunity by OX40 signaling. 
Since CD8+ T cells are involved in cutaneous anti-tumoral immunity as well we inoculated mice 
with B16 melanoma cells resulting in a significantly increased tumor growth associated with the 
down-regulation of cytolytic molecules in CD8+ T cells from K14-OX40 tg compared to wt mice. 
As OX40/OX40L signaling modulates the numbers and function of regulatory T cells (Treg) or 
myeloid-derived suppressor cells (MDSC) we next characterized these cell subsets. In HSV-infected 
tg mice Treg numbers were comparable to wt controls. However, in melanoma-bearing tg mice we 
identified similar numbers of Treg but increased levels of MDSC in tumor tissue suggesting that in a 
tumor environment OX40 signaling might promote the induction of MDSC and thereby contribute to 
the down-regulation of MHC class-I mediated anti-tumoral immunity. Together, we demonstrated a 
dual role of cutaneous OX40/OX40L signaling in anti-viral and anti-tumoral immunity by expanding 
CD8+ effector T cells but simultaneously inducing MDSC, which in tumor-bearing mice might 
inhibit the cytolytic activity of CD8+ T cells.    
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Anti-tumor immune system triggered by innate immune pattern recognition of melanoma
H Ikushima and T Taniguchi Department of Molecular Immunology, Institute of Industrial 
Science, Max Planck-The University of Tokyo Center for Integrative Inflammology, The 
University of Tokyo, Tokyo, Japan
Although cancer immunotherapies through the control of adaptive immune responses have been 
energetically studied both in basic and clinical research fields, it has not been fully elucidated how 
innate immune system, the other important axis of immunity, recognizes and targets tumor cells. In 
particular, it is still enigmatic whether and how innate immune pattern recognition receptors contrib-
ute to anti-tumor immune responses, although these receptors are well known to play important roles 
in innate immune responses against invading pathogens through recognition of pathogen-associated 
molecular patterns (PAMPs) such as lipopolysaccharide on bacteria and beta-glucan on fungi. In this 
study, we demonstrate that the innate immune pattern recognition receptor Dectin-1 expressed on 
dendritic cells and macrophages is critical to NK cell-mediated killing activity against melanoma. 
We also show that melanoma-triggered Dectin-1 signaling in dendritic cells and macrophages is 
instigated by the receptor recognition of N-glycan structures on melanoma cells, which we term 
tumor-associated molecular patterns (TAMPs). The TAMP-Dectin-1 signaling leads to the activa-
tion of the downstream transcription factor, Interferon Regulatory Factor 5 (IRF5), and subsequent 
induction of genes required for the full-blown killing activity of NK cells. The importance of these 
events is underscored by the observation of massive melanoma metastasis in mice genetically defi-
cient in either Dectin-1 or IRF5. Thus, these results reveal a hitherto unrecognized facet of pattern 
recognition receptors in the orchestration of anti-tumor innate immune responses; recognition of 
TAMPs. This study is the first to demonstrate that an innate immune pattern recognition receptor 
potentiates anti-tumor immune responses, offering new insight into anti-tumor activity of the innate 
immune system with implications for anti-tumor immunotherapy.    
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Interleukin (IL)-26 overexpressed in psoriatic skin has antimicrobial and pro-inflammatory 
functions 
J Di Domizio,2 S Meller1 and M Gilliet2 1 Heinrich-Heine-University, Duesseldorf, Germany 
and 2 University Hospital of Lausanne, Lausanne, Switzerland
Psoriasis is a common chronic-relapsing inflammatory skin disease initiated by activation of plas-
macytoid dendritic cells (pDC) and mediated by Th17 cells producing IL-17A/F, IL-22 and IL-26. 
While the functions of IL-17 and IL-22 are well characterized, the role of IL-26 in the inflammatory 
process is less clear. Here we found that TH17-derived IL-26 has a cationic amphipathic structure, 
which allows direct killing of extracellular bacteria via membrane pore formation. Furthermore, 
TH17-derived IL-26 formed complexes with bacterial- and self-DNA released by dying bacteria or 
host cells, respectively. The resulting IL-26-DNA complexes triggered potent type I IFN production 
by pDC via Toll-like receptor 9 activation. In psoriasis IL-26 was highly expressed in lesional skin, 
reaching levels relevant for pDC activation. Moreover, repetitive skin injection of IL-26 induced 
type I IFN production by pDC and the development of a psoriatic phenotype in mice. These findings 
identify an antimicrobial and pro-inflammatory function of TH17-derived IL-26 and suggest a key 
role in the pathogenesis of psoriasis.    
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Transforming Growth Factor Beta Induces a SAMHD1-independent Post-Entry Restriction to 
HIV-1 Infection of Immature Langerhans Cells
M Czubala,1 M Ivory,1 F Blanchet2 and V Piguet1 1 Infection and Immunity, Cardiff University, 
Cardiff, United Kingdom and 2 5UMR5236 CNRS, UM1,UM2, CPBS, Montpellier, France
Langerhans cells (LC) are among the first immune cells to encounter HIV-1 during mucosal trans-
mission. LC were previously reported to be partly resistant to HIV-1 infection, due to the presence 
of langerin (CD207) on their cell surface. However, it is not known if other restrictions to HIV-1 
infection are present in LC. SAMHD1 was previously identified as a critical post-entry restriction 
factor to HIV-1 infection in myeloid cells, including myeloid dendritic cells (DC). Here we show 
that SAMHD1 is also expressed in LC but, in contrast to myeloid DC, the degradation of SAMHD1 
(mediated by Vpx) does not result in rescue of HIV-1 infection in LC. Importantly, Vpx-mediated 
degradation of SAMHD1 in dermal DC, freshly isolated from human skin, led to a strong increase 
in HIV-1 replication. In contrast, down-regulation of SAMHD1 expression in skin-derived LC did 
not result in a statistically significant enhancement of HIV-1 infection. We further demonstrate 
that the restriction activity in LC was induced by TGF-β and was present in immature LC at a 
steady-state. LC restrictive activity against HIV-1 did not require IFN-α or the cellular restriction 
factor MX-2. In the absence of SAMHD-1, LC did not produce IFN-β when infected with VSV-G 
HIV-GFP, confirming that this cellular protein is definitely not involved in lowering viral replication 
and, therefore, impeding the engagement of potential intracellular sensing mechanisms in LC. 
Strikingly, maturation of LC by TLR-2/TLR-1 agonists (Pam3CSK4) or TNF-α partially abolished this 
LC-specific restriction activity against HIV-1. In conclusion, we report a novel TGF-β-dependent 
HIV-1 post-entry restriction activity, specifically present in immature LC, which protects these cells 
from HIV-1 infection. Modulating or enhancing this natural resistance of LC to HIV-1 infection may 
offer novel avenues to block HIV-1 in the early stages of viral transmission.    
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Innate stimulus triggering preferential Th17 response in HLA-Cw6+ gutatte psoriasis through 
skin-specific memory T cells, epidermal cells, and Streptococcus pyogenes interaction
E Ruiz Romeu,2 M Ferran,1 M Sagristà,1 A Giménez-Arnau,1 A Celada,2 R Pujol1 and 
L Santamaria-Babi2 1 Dermatology, IMAS, Barcelona, Spain and 2 Physiology and 
Immunology, University of Barcelona, Barcelona, Spain
Psoriasis has been considered to be triggered by innate stimuli and especially in guttate-type onset, a 
clinical presentation often preceded by Streptococcus pyogenes (Sp) pharyngitis. Although Th17-cy-
tokine immune response is clinically validated in psoriasis, there are no studies focusing on an 
antigen-specific Th17-induced response in these patients by Sp. We investigated how guttate patients 
with flares associated to previous streptococcal pharyngitis, and also carrying the well-known 
genetic risk factor HLA-Cw6, are responding to Sp by coculturing blood-derived skin-homing CLA+ 
T cells together with autologous lesional epidermal cells in presence of a Sp extract (SE). Analysis of 
cytokines in 5 days supernatants revealed that SE induced a predominant Th17-cytokine response 
in cocultures derived from these gutatte patients and it was inversely correlated with time elapsed 
since lesions onset. On the contrary, no significant cytokine response was observed in cocultures 
containing cells from HLA-Cw6- guttate patients and/or with no previous pharyngitis episode, or 
from healthy control subjects. Furthermore, these conditioned supernatants exerted a psoriasis-like 
gene expression profile in keratinocytes by upregulating mRNA expression of antimicrobial peptides 
(DEFB4, S100A7 and LCN2), cytokines and chemokines (IL36G, IL8, CXCL9, CXCL10 and CXCL11) 
and downregulating expression of key molecules for skin barrier integrity (FLG and LOR). Moreover, 
the mRNA expression of those IL-17-related genes significantly correlated with the amounts of 
IL-17A in SE-activated cocultures supernatants. In conclusion, these data suggest that in HLA-Cw6+ 
guttate patients, Th17 circulating memory CLA+ T cells increase shortly after streptococcal throat 
infection, which might indicate that IL-17 might be a major effector immune factor in early events 
of the disease.    
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Emerging role of polyfunctional CXCR3+/CCR6+ effector memory T cells in vitiligo
J Seneschal, A Darrigade, B Dessarthe, C Vernisse, J Rambert, F Lucchese, N Boukhedouni, 
A Taieb, K Ezzedine and K Boniface Dermatology, Bordeaux University, Bordeaux, France
Vitiligo is the most frequent skin depigmenting disorder, with a major social impact and no effective 
treatment. The pathological hallmark of vitiligo is the loss of melanocytes associated with autoim-
mune components involving both CD4+ and CD8+ T cells. However the phenotype and contribution 
of effector memory T (TEM) cell subsets remain to date unclear and controversial due to the lack of 
extensive analyses in human and animal models reproducing clearly the complexity of the disease. 
We aimed to decipher the phenotype and function of circulating and skin TEM in human vitiligo 
and analyze their contribution to melanocytes loss. First, by analyzing side-by-side circulating and 
skin TEM, we observed a decreased frequency of blood circulating CXCR3
+ (Th1), CCR6+/CD161+ 
(Th17) and CXCR3+/CCR6+ (Th1/Th17) in vitiligo patients compared to healthy controls. This was 
associated with elevated frequency of these TEM cell subsets in vitiligo peri-lesional skin, respond-
ing to their cognate ligands expressed by keratinocytes (CCL20 and CXCL10), as confirmed by 
flow-cytometry and in-situ immunofluorescence microscopy studies. Cytokine secretion profile of 
these blood and skin TEM subsets isolated from vitiligo patients readily identified interferon (IFN)-γ, 
tumor necrosis factor (TNF)-α, interleukin (IL)-17, and IL-22 as potential pro-inflammatory cytokines 
involved in the disease pathogenesis. We next analyzed the activities of these soluble factors on 
primary cultures of melanocytes and 3D reconstructed human epidermis with melanocytes. We 
observed differential effects on melanocytes, leading to their loss and reproducing observations 
made in patients’ peri-lesional skin. All together, these findings add a more precise understanding 
of the TEM immune response in vitiligo, and highlight potential targets for therapeutic intervention 
in vitiligo, a disease suffering from a lack of effective treatment.    
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Sensory fibers drive IL-23 from CD301b+ dermal dendritic cell to drive cutaneous host 
defense against Candida albicans infection
SW Kashem and D Kaplan Dermatology, University of Minnesota, Minneapolis, MN
Innate resistance to Candida albicans in mucosal tissues requires production of IL-17A by tissue 
resident cells early during infection. In the skin, we found that dermal TCRγδ T cells were a dominant 
source of IL-17A during C. albicans infection and were required for pathogen resistance. Induction 
of IL-17A from dermal TCRγδ T cells and resistance to C. albicans required IL-23 from CD301b+ 
dermal dendritic cell (dDC) and was independent of CD103+ dDC and Langerhans cells. In addi-
tion, we found that pain associated sensory neurons are directly activated by C. albicans. Chemical 
ablation of TRPV1+ neurons and mechanical denervation resulted in reduced expression of IL-23 
by CD301b+ dDC and increased susceptibility to C. albicans infection that could be rescued by 
the addition of the neuropeptide CGRP. These data define a model in which nociceptive pathways 
in the skin drive production of IL-23 by CD301b+ dDC resulting in IL-17A from TCR γδ T cells and 
resistance to cutaneous candidiasis.    
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Endothelial cell junctions are tightened by regulatory T cells via induction of a cAMP, VE-cad-
herin dependent mechanism, leading to reduced inflammation in contact hypersensitivity 
reactions
S Ring, A Enk and K Mahnke University Hospital Heidelberg, Heidelberg, Germany
We have recently shown that the elicitation phase of contact hypersensitivity (CHS) reactions, a 
murine model for allergic contact dermatitis in humans, is suppressed by regulatory T cells (Treg). 
As mediator we identified the production of adenosine (ADO) by the ectonucleotidases CD39 and 
CD73, which are constitutively expressed by Treg. But as to how Treg-derived ADO reduces the ear 
swelling reaction in the TNCB-induced CHS is not clear. To investigate the underlying mechanisms, 
in vitro cultures were set up using the endothelial cell line (EC) bEnd.3, freshly isolated Treg and 
effector T cells (Teff). After stimulation of EC with TNFα, mimicking activation, we observed increased 
adherence of Teff to EC even under shear force conditions. This adhesion was blocked by Treg. 
In addition, also transmigration of Teff through EC, plated in Boyden chambers, was substantially 
reduced in presence of Treg. Of note, CD39 deficient (CD39-/-) Treg as well as blockade of ADO 
A2A receptors on EC nullified the Treg effects on adhesion as well as on transmigration, indicating 
involvement of ADO signalling in mediating these effects. During investigation of the Treg-induced 
signal transduction events, we found that Treg-derived ADO increased cAMP levels and GTPase 
activity (Rac, Rho, CDC42) in activated EC. The functional impact of these signalling events on EC 
was then demonstrated microscopically, as we can show that in Treg-treated EC radial actin stress 
fibers become reorganized to circumferential actin bundles and that VE-cadherin expression along 
adjacent EC is increased. In summary these data indicate that Treg-derived ADO downregulates 
permeability of the endothelium by engaging A2A receptors, inducing GTPase activity and tightening 
the VE-cadherin dependent adherens junctions. This reduced permeability may preclude Teff from 
entering inflamed tissues and thus contribute to the anti-inflammatory effect of Treg.    
424
Human T-cell Leukemia Virus type 1 can modulate TLR-induced Dendritic Cells Activation 
via C-Type Lectin Receptors
T Shimauchi,1 F Blanchet,1 K Finsterbusch,1 M Czubala,1 T Easter,1 K Ladell,2 D Price,2 
C Bangham,3 Y Tokura4 and V Piguet1 1 Department of Dermatology & Wound Healing, 
Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, United 
Kingdom, 2 Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, 
United Kingdom, 3 Section of Immunology, Imperial College London Wright-Fleming Institute, 
London, United Kingdom and 4 Department of Dermatology, Hamamatsu University School 
of Medicine, Hamamatsu, Japan
Human T-cell Leukemia Virus type 1 (HTLV-1) can bind to dendritic cells (DCs), and the DCs har-
boring viruses can transmit them to CD4+ T cells via cell-to-cell contact (virological synapse). During 
the process of this trans-infection, we previously showed that Toll-like receptor (TLR) 4-induced 
maturation as well as pro-inflammatory cytokines production of human immature monocyte derived 
DCs (iDCs) was inhibited by cell-to-cell contact with HTLV-1 infected cell line (MT2). However, 
the mechanisms of HTLV-1-induced modulation of TLR responses on iDCs are still unclear. We 
here demonstrated that iDCs co-cultured with MT-2 led to phosphorylate the c-Raf, MEK1/2, ERK, 
which are novel DC-SIGN or other C-type lectin receptors (CLRs) signaling pathways. In addition, 
MEK1/2 inhibitor (U0126) could inhibit the phosphorylation of its downstream pathway, ERK. Next, 
we generated the DC-SIGN knockdown iDC by transduction with siRNA-expressing lentiviral vector 
(LV) after the pretreatment with SIV virus-like particles containing Vpx for the transient SAMHD1 
degradation and permissiveness to LV infection. Compared to the non-treated iDC or LV-empty 
vector transduced iDC, LV-siDC-SIGN transduced iDC have a tendency to restore the LPS-induced 
IL-6 and TNF-a production under the co-culture with MT-2. However, the IL-12p40/p70 production 
could not be restored. These data suggested that HTLV-1 or virus associated components expressed 
on the surface of infected cells can bind to DC-SIGN or other CLRs and induce the c-Raf/MEK/ERK 
signaling pathway, resulting in the modulation of TLR responses in DCs.    
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Acute Graft-versus-Host-Disease likely results of skin resident T cells reaction to newly gen-
erated dendritic cells from engrafted stem cells
TR Matos, KF Lima, CP Elco, A Gehad, JE Teague, TS Kupper and R Clark Brigham and 
Women’s Hospital and Harvard Medical School, Boston, MA
Acute Graft-versus-Host-Disease(aGvHD) is defined as a clinical syndrome caused by T cell–medi-
ated attack on normal tissues of the recipient. We previously observed that conditioning regimens 
prior to stem cell transplantation do not fully deplete skin-resident memory T cells(TRM). TRMs were 
only cleared from the skin when the graft T cells were generated. Thus, there must be a window of 
time in which recipient T cells are still present in the skin and blood donor graft T cells have not 
yet been generated. During this time frame aGvHD can occur. We hypothesize that aGvHD can 
in part result of surviving skin resident T cells of the recipient reacting with dendritic cells from the 
donor graft that have newly migrated into the skin. A humanized mouse model of GvHD was used 
to compare the effects of either injecting allogeneic peripheral blood mononuclear cells (PBMCs) or 
allogeneic monocytes. Abdominal skin, which has TRM, was grafted to NOD/SCID/IL-2Rg-/- mice 3 
weeks before i.v. injection of allogeneic T cells from PBMCs(CD25-) or monocytes, and skin grafts 
were harvested 3 weeks after injections. We show that injection of monocytes is sufficient to gen-
erate morphologic and histologic features of graft induced host response comparable to injection of 
PBMCs. TCR sequencing shows similar T cell clonality between groups and higher when compared 
to not-injected control group. Furthermore, RT-PCR analysis presented no statistical difference of 
CD3, CD8, TNF-α, IL-9, IL-17 between injected groups. In short, we have shown that interaction 
between graft monocytes and skin resident T cells results in proliferation of T cells and production 
of cytokines known to participate in the pathogenesis of GvHD. This findings support aGvHD to 
be in part result of newly generated dendritic cells from the engrafted stem cells, which migrate 
into the skin and present allo-antigens to skin TRM cells. Lastly, we have demonstrated that human 
TRM can mediate graft induced host response akin GvHD in human skin.    
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Oncostatin M induces IL-33 through STAT3 pathway in normal human epidermal keratinocytes
H Tsuda,1 M Komine,1 S Tominaga2 and M Ohtsuki1 1 Dermatology, Jichi Medical University, 
Shimotsuke, Japan and 2 Biochemistry, JichiMedical University, Shimotsuke, Japan
IL-33, a member of IL-1 superfamily, is an inflammatory cytokine and a key molecule for polar-
ization to Th2 inflammation, while it also works as a nuclear protein in the nucleus. It is mainly 
produced in epithelial and endothelial cells. We previously reported that IL-33 was induced by 
UVB, IL-17A and IFN-γ in normal human epidermal keratinocyte (NHEKs). We also revealed that 
IL-33 was expressed in the nucleus of epidermal keratinocytes in the lesional skin of psoriasis. Our 
previous study demonstrated that STAT1 and/or STAT3 pathway were involved in the expression 
of IL-33. However, the detail of IL-33 expression mechanism is still unclear. Oncostatin M (OSM) 
is a member of IL-6 family which utilizes STAT3 and gp130 for signal transduction. OSM induces 
pulmonary inflammation and fibrosis, and also reported to be involved in the pathogenesis of pso-
riasis. We showed in this study that OSM induced IL-33 expression both mRNA and protein levels 
in a dose- and time- dependent manner in NHEKs. JAK inhibitor and EGFR inhibitor suppressed 
IL-33 expression induced by OSM. In order to evaluate the involvement of STAT1 and/or STAT3, 
we utilized adenovirus vector expressing dominant negative mutant of each molecule. STAT1 
dominant negative did not affect the induction of IL-33, however STAT3 dominant negative clearly 
down regulated IL-33 induction both at mRNA and protein levels. SOCS3, a negative regulator of 
JAK3, down regulated IL-33 expression. A series of luciferase constructs of IL-33 promoter region 
with several deletion mutants was made, which revealed that IFN-γ and OSM recognized the same 
region on IL-33 promoter. Above results indicate that STAT3 is required for the induction of IL-33 
by OSM in NHEKs, and that the existence of IL-33 may be of importance in psoriasis.    
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Macrophages Regulate IL-17-Associated Skin Inflammation in Mice with Dlx3-deficient 
keratinocytes
Y Ogawa,1 J Kim,2 MI Morasso2 and MC Udey3 1 Dermatology, Yamanashi School of 
Medicine, Yamanshi, Japan, 2 Laboratory of Skin Biology, National Institute of Arthritis, 
Musculoskeletal and Skin Diseases, Bethesda, MD and 3 Dermatology Branch, National 
Cancer Institute, Bethesda, MD
The transcription factor Dlx3 induces differentiation of keratinocytes (KC). Epidermal deletion of 
Dlx3 in K14cre;Dlx3kin/f mice (cKO) leads to accumulation of gdT17 cells in skin and a psoriasis-like 
phenotype. This study addresses the role of skin antigen-presenting cells (APCs) in this phenotype. 
Leukocytes from full-thickness dorsal skin were quantified and characterized using FACS and qPCR. 
Enumeration of LC, DC and macrophages (Mph) revealed that Mph were the most frequent APCs, 
and they were 3-fold more prevalent in cKO than in WT skin. IL-1, TNF-a and IL-23 regulate skin 
gdT17 numbers in mice. In cKO skin, IL-1 and TNF-a mRNAs were primarily expressed by Mph, 
whereas IL-23 mRNA was present in LC, DC and Mph. Injection of aCSF-1R mAb into cKO mice 
depleted almost all LC and Mph, but not DC, with associated decreases in IL-23, IL-1 and TNF-a 
mRNAs in skin. Numbers of skin gdT17 cells were also decreased in mAb-treated mice. In WT 
skin, Mph exhibited a uniform surface phenotype (CD45+MHCII+F4/80+EpCAM-). In contrast, two 
additional Mph populations were present in cKO skin (F4/80+EpCAM+ and F4/80highEpCAM- Mph). 
EpCAM+ Mph highly expressed IL-23 and IL-23R mRNAs, whereas F4/80high Mph expressed IL-1, 
TNF-a and iNOS mRNAs. IL-36b, which is upregulated in Dlx KO KC, enhanced IL-23 mRNA in 
EpCAM+ Mph. We propose that IL-36 overproduced by Dlx3 KO KC acts on Mph, including a novel 
EpCAM+ population, inducing coordinate production of IL-1, TNF-a and IL-23, that in turn results in 
dermal accumulation of gdT17 cells and development of a psoriasis-like phenotype.    
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Expansion of circulating CD49b+LAG3+ type 1 regulatory T cells in human skin chronic 
graft-versus-host disease
A de Masson,1 H Le Buanec,1 M Robin,2 M Bagot,1 A Bensussan,1 G Socié2 and J Bouaziz1 1 
INSERM U976, Paris, France and 2 Saint Louis Hospital, Paris, France
Chronic graft-versus-host disease (cGVHD) is the main cause of morbi-mortality after allogeneic 
hematopoietic stem cell transplantation (AHSCT). Skin is the most affected organ and skin cGVHD 
may be highly disabilitating, especially in its sclerotic form. The pathophysiology of cGVHD involves 
T cell homeostatic abnormalities including low natural regulatory T cells (nTreg) cell numbers 
and elevated IL-7 serum levels. Type 1 adaptive regulatory T cells (Tr1 cells) have been recently 
identified in humans as CD3+CD4+CD45RA-CD49b+LAG3+ cells. These cells have been shown 
to have IL-10-mediated immunosuppressive properties. We prospectively studied Tr1 and nTreg 
frequencies in 19 patients including 14 AHSCT recipients with or without skin cGVHD. Longitudinal 
data were acquired in 3 patients with sclerodermiform cGVHD before and after IL-2 treatment. The 
mean age of patients was 40, half were men. Patients with skin cGVHD had higher frequencies 
of Tr1 cells (mean, 20% of CD4 T cells) than AHSCT recipients without cGVHD (5.5%, p=0.009) 
and healthy donors (6.9%, p=0.02). An inversion of the Tr1/nTreg ratio was observed in patients 
with skin cGVHD as compared with AHSCT recipients without cGVHD and healthy donors. In 3 
patients treated with low doses IL-2 for sclerodermiform cGVHD, Tr1 frequencies dropped down 
from the first week after the start of IL-2 (from 24 to 13% on average). By contrast, nTreg frequencies 
increased from day 7 (from 6 to 13.2% on average). In all patients, Tr1 cells expressed low levels 
of IL-2 receptor a, and high levels of IL-7 receptor a as compared with nTreg. These results are 
consistent with the increased levels of IL-7 in cGVHD, which could stimulate Tr1 cells expansion. 
They are in line with the absence of expansion of Tr1 cells after IL-2 treatment. The Tr1 cell drop 
after IL-2 treatment could involve the deprivation of IL-7. These results suggest a peculiar role of 
Tr1 cells in the context of skin chronic GVHD.    
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MicroRNA-146a is up-regulated in psoriasis keratinocytes and is induced by IL-36α
A Srivastava, F Meisgen, NX Landén, M Ståhle, A Pivarcsi and E Sonkoly Medicine, Karolinska 
Institutet, Stockholm, Sweden
Psoriasis is the most prevalent immune mediated skin disease in adults and affects 2-4% of Cau-
casian population. MicroRNAs are small, non-coding, regulatory RNA molecules which regulate a 
variety of biological process. Their unique signatures in psoriatic lesions have been implicated in 
the pathogenesis and progression of the disease. Here, we show that miR-146a was up-regulated 
in keratinocytes isolated from psoriatic skin lesions and was strongly induced in keratinocytes upon 
IL-36α stimulation in three-dimensional epidermal equivalents, suggesting a functional link to 
psoriasis. A single stimulation with IL-36α resulted in rapid and transient induction of inflammatory 
mediators such as IL-8 and TNF-α in primary keratinocytes, while miR-146a was induced early 
and remained up-regulated up to 96 hours. Overexpression of miR-146a suppressed the induction 
of inflammatory mediators by IL-36α in keratinocytes, while inhibition of endogenous miR-146a 
further increased IL-36α -induced expression of inflammatory mediators. We showed that miR-146a 
induction by IL-36α was mediated via MyD88, Irak1, NF-κB and JNK, and can be inhibited by 
the receptor antagonist IL-36ra. Furthermore, miR-146a diminished the ability of keratinocytes to 
activate endothelial cells and to chemotactically attract neutrophils. In conclusion, our data suggest a 
model where IL-36α, a cytokine overexpressed in psoriasis skin, induces miR-146a in keratinocytes, 
which in turn acts as a negative feedback to control the excessive inflammation in the psoriatic skin.   
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Intradermal targeting of HIV-p24-coated nanoparticle vaccine into the skin induces Dendritic 
Cells and T cells specific immunity
S Caucheteux,1 M Ivory,1 J Mitchell,1 F Blanchet,5 F Nestle,3 J Hubbell,2 A Moris4 and 
V Piguet1 1 Infection and Immunity, Cardiff, United Kingdom, 2 Institute of Bioengineering, 
Lausanne, Switzerland, 3 St. John’s Institute of Dermatology, London, United Kingdom, 4 
Unité Virus et Immunité, Paris, France and 5 UMR5236 CNRS, Montpellier, France
Professional antigen presenting cells like Langerhans cells in the epidermis and Dendritic Cells (DC) 
in the dermis are found at high densities in the skin and represent effective targets for immunization. 
Using a nanoparticle formulation we have investigated the vaccine potential of HIV-p24-coated 
polypropylene sulfide nanoparticles (p24NP) to induce immune responses against HIV-1 virus. Our 
results show that p24NP does not induce early maturation nor affect the function of immature DC 
or Langerhans cells. We demonstrated that p24NP’s rapid uptake by DCs induces a strong response 
of HIV-specific CD4 and CD8 T cells clones in DC-T cells cocultures. Using a micro needle system, 
we show efficient delivery of the nanoparticles into the skin. Furthermore, we show that DC-CD4 
T cell vaccination induces a strong IFN-γ CD4 T cell secondary response to HIV-1 infection. Thus 
HIV-p24-coated polypropylene sulfide nanoparticles delivered into the skin have a great potential 
as efficient vaccine against HIV-1.    
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Curcumin protects from inflammatory autoimmune disease by suppressing IL-12/IL-23p40 
J Brück, I Glocova, J Geisel, J Holstein, M Röcken, A Yazdi and K Ghoreschi Department of 
Dermatology, University of Tübingen, Tübingen, Germany
Curcumin (diferuloylmethane) is a naturally occurring yellow pigment isolated from the rhizomes of 
the plant Curcuma Longa. It has been reported that curcumin may possess anti-inflammatory activ-
ities and therefore is traditionally used in inflammatory disorders in some regions of Asia. However, 
the underlying mechanisms that could explain its beneficial activity during inflammation are not 
fully understood. In this study we analyzed whether curcumin is able to modify immune responses 
in vitro and in vivo. First, we investigated the potential anti-inflammatory activities of curcumin on 
mouse dendritic cells (DC) in vitro. Gene expression of curcumin treated DC or control DC acti-
vated through TLR4 was analyzed by PCR-arrays. Curcumin treated DC showed an upregulation of 
genes of the TNF superfamily, certain caspases and NFkB inhibitory genes. Interestingly, curcumin 
impaired the production of the cytokines interleukin (IL-)12 and IL-23 by TLR4-activated DC. To 
further investigate the effects of curcumin on immune responses in vitro we co-cultured isolated 
CD4+ T cells from mice immunized with a myelin peptide in CFA together with fresh APC and PLP 
peptide in the presence or absence of curcumin. After re-stimulation, curcumin treated cultures 
showed an inhibition of the Th1 and Th17 cytokines IFN-g and IL-17, while the expression of the Th2 
cytokines IL-4 and IL-10 increased. To assess the in vivo effects of curcumin, mice were immunized 
with myelin peptide in CFA, treated with curcumin or vehicle and followed for the development of 
autoimmune encephalomyelitis (EAE). Control mice developed severe symptoms of EAE, while mice 
treated with curcumin remained healthy or developed only mild disease. The protection from EAE 
by curcumin treatment was associated with a suppression of IL-12/IL-23p40 and subsequent Th1 
and Th17 responses in vivo. Taken together curcumin treatment seems to be a promising approach 
for improving IL-12/IL-23-dominated autoimmune diseases by using a natural extract.    
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Does human skin harbor macrophage progenitors?
J Gherardini,1 J Chéret,1 M Alam,1 Y Uchida,1 M Bertolini1 and R Paus2 1 Dermatology, 
University of Münster, Münster, Germany and 2 Centre for Dermatology Research, Institute 
of Inflammation and Repair, University of Manchester, Manchester, United Kingdom
In mice, yolk sac-derived tissue-resident macrophages (trMΦ) are distinguished from monocyte-de-
rived infiltrating MΦs. Under non-inflammatory conditions, the “physiological” number of MΦs in 
murine peripheral tissues, incl. skin, is thought to be maintained by self-renewing trMΦs. However, 
it is as yet unknown whether such cells exist in human skin. Therefore, we asked in organ-cultured 
full-thickness human skin, in which surrogate “neurogenic inflammation” was induced by the 
pro-inflammatory neuropeptide, substance P (SP), whether human skin also harbors trMΦ precur-
sors. In the absence of perfused vasculature or bone marrow, SP treatment significantly increased 
the number of MHC class II+ cells (quantitative immunohistomorphometry). That most of these are 
likely to represent trMΦs was supported by the finding that the number of CD68+ MΦs was also 
increased in the test group. Since almost no CD68+/Ki-67+, CD68+/PH3+ or EdU+/CD68+ cells were 
detectable in test or control skin, proliferation is highly unlikely to have accounted for the numeric 
increase of CD68+ cells. Moreover, SP did not suppress MΦ apoptosis, as shown by CD68/TUNEL 
double-immunostain. Since CD34+ cells were often seen to reside in close contact with CD68+ 
cells, namely in SP-treated skin, we are now probing the hypothesis that human skin trMΦs arise 
from CD34+ cells or collaborate with them during trMΦs differentiation. These pilot data suggest 
that human skin harbors trMΦ progenitor cells and that their differentiation can be triggered by 
neurogenic inflammation. This assay provides a new tool for interrogating human skin MΦ biology 
ex vivo and raises the intriguing question how many of the altered, persisting, pro-inflammatory 
MΦs seen in neurogenic skin inflammation (e.g. atopic dermatitis) actually arise from trMΦ, rather 
than from infiltrating monocytes.    
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A role for CD73-derived adenosine in the suppressive activity of regulatory B cells
M Schiller, A Enk and K Mahnke University Hospital Heidelberg, Heidelberg, Germany
B cells are well characterized as pro-inflammatory, antibody producing and antigen presenting 
cells. However, recently also a suppressive subset of B cells, i.e. IL-10 producing Breg cells, has 
been identified in mice. Their role in preventing autoimmunity as well as counteracting anti-tumor 
response is well established. They are mainly characterized by expression of CD19, CD1d, CD5 and 
their immunosuppressive function is conveyed by production of IL-10. But we and others recently 
found also expression of the ectonucleotidase CD73 on a subset of Breg. In order to characterize 
this novel subset, we analysed B cells in spleens, lymph nodes (LN) and peritoneum by FACS. In 
LN and spleens we found only 10-15% of all CD19+ B cells being positive for CD73. In contrast, 
in peritoneum, which serves as reservoir for Breg, up to 40% of all B cells expressed CD73. When 
analysing production of IL-10 by B cells after in vitro stimulation, our data indicate that CD73+ as 
well as CD73- Breg produce comparable amounts of IL-10. However, CD73 functions as ectonu-
cleotidase and enables B cells to produce immunosuppressive adenosine from extracellular ATP. 
We therefore further analysed the suppressive function of CD73+ in comparison to CD73- Breg. 
To this end we cultivated sorted B cells from control (wt) and CD73 deficient animals (CD73-/-) 
together with Ovalbumin pulsed dendritic cells and OT-II T cells. Here we found that B cells from 
CD73-/- animals produced less adenosine and showed significantly reduced suppressive activity 
on T cell proliferation as compared to wt controls. These data indicate that a subset of CD73+ 
Breg may suppress immune reactions by adenosine production and analysis of the temporal and 
spatial distribution during tumor growth and other malignancies is of importance to counteract their 
immune suppressive actions by adenosine antagonists.    
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Expansion of thymus-derived Tregs exhibiting a Th2-like phenotype is promoted in atopic 
dermatitis
V Moosbrugger-Martinz,1 CH Tripp,1 R Gruber,1 BE Clausen,2 D Finke,3 C Heufler,1 
H Fiegl,4 M Schmuth1 and S Dubrac1 1 Department of Dermatology and Venereology, 
Medical University of Innsbruck, Innsbruck, Austria, 2 Institute for Molecular Medicine, 
University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany, 
3 Developmental Immunology, Department of Biomedicine, University of Basel, Basel, 
Switzerland and 4 Department of Gynecology and Obstetrics, Medical University of 
Innsbruck, Innsbruck, Austria
Atopic dermatitis (AD) is a widespread inflammatory skin disease with an early onset, characterized 
by pruritus, eczematous lesions, and skin dryness. This chronic relapsing disease is believed to 
be primarily due to a defective epidermal barrier function associated with genetic susceptibility, 
immune hyper-responsiveness of the skin, and environmental factors. Although the important role 
of abnormal immune reactivity in the pathogenesis of AD is widely accepted, the role of regulatory 
T cells (Tregs) remains elusive. We found higher frequencies of overall Tregs with specific expansion of 
thymus-derived Tregs in mice and patients with AD starting early in the development of the disease. 
Emigrated skin-derived dendritic cells are required for Treg induction and Langerhans cells (LCs) are 
responsible for the biased expansion of thymus-derived Tregs in this mouse model of AD. Moreover, 
we found increased percentages of IL-13-producing Tregs in skin draining lymph nodes (sdLNs), simi-
lar to Th2 Tregs found in skin from AD patients. More thorough investigation revealed thymus-derived 
Tregs as the main source of IL-13 in our AD model. While the expansion of thymus-derived Tregs might 
be attributed to LCs, their cytokine production might be rather determined by other cells or factors 
from the micromilieu. Hence, these Th2 Tregs instead of alleviating AD symptoms might actively 
contribute to the disease. Therefore, future investigations on the role of thymus-derived Tregs in the 
pathogenesis of AD and the conditions of their conversion into Th2 cells are new routes of research 
that will help to further decipher the etiopathology of AD.    
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Effective melanoma defense by turning tumor resident mast cells into T-cell recruiting immune 
sentinels
S Kaesler,1 Y Skabytska,1 F Wölbing,1 M Koeberle,1 W Kempf,1 T Volz,1 M Röcken2 and 
T Biedermann1 1 Dermatology, TU Munich, Munich, Germany and 2 Dermatology, 
University of Tübingen, Tübingen, Germany
Increasing incidence and a poor prognosis of advanced and metastatic melanoma are underlying 
the enormous efforts in research for new treatment strategies. Clinical trials with immune check-
point modulators now reported increased overall survival, but long term treatment responses are 
still limited to few patients and predictors for treatment success are tumor specific T-cell precursor 
frequencies at tumor sites. The role of mast cells (MC) in cancer biology received increasing attention 
as MC are often recruited to the sites of tumor development and growth. Although it is believed that 
tumors benefit from MC and their released mediators, in different tumor types increased MC numbers 
were associated with cancer progression or improved survival of patients. As MC phenotypes and 
effector functions differ in response to local micromilieus, we hypothesized that checkpoint inhibi-
tors may contribute to shaping the tumor micromilieu with consequences on MC immune behaviour. 
We characterized how appropriate signals targeting MC effectively drive melanoma resident MC 
to amplify anti-melanoma immune responses. As signal effectively initiating MC activation and 
melanoma defence we identified a systemic LPS signature in humans treated with immune check-
point inhibitor as possible trigger for re-programming melanoma resident MC. In mouse models, 
complementing the tumor micromilieu with TLR4 ligand LPS initiated melanoma defense. In depth 
characterization revealed that this melanoma defense was dependent on tumor-specific T cells and 
that LPS specifically activated MC, which in turn recruited tumor infiltrating T cells (TILs) by secretion 
of CXCR3-ligand IP-10 orchestrating tumor defense. Our data provide strong evidence for a new 
strategy namely to target cancer resident immune cells, taking advantage of their plasticity, and to 
turn them against the tumor by using appropriate signals such as TLR ligands.    
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Specific targeting of CD14+ dermal DCs and macrophages of human skin by Chikungunya 
virus envelope protein E2.
M Cumin,1 A Hoste,1 O Chaloin,1 P Despres,2 CG Mueller1 and V Flacher1 1 CNRS UPR3572, 
Laboratory of Immunopathology and Therapeutic Chemistry / Laboratory of Excellence 
Medalis, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France and 2 Flavivirus-
Host Molecular Interactions Laboratory, Institut Pasteur, Paris, France
Targeting human skin antigen-presenting cells (APCs) that control the fate of T cells represents an 
attractive therapeutic option in autoimmune diseases or cancer. Epidermal Langerhans cells (LCs) 
and CD1a+ dermal dendritic cells (dDCs) traffic towards skin-draining lymph nodes upon stimu-
lation. CD14+ dDCs and dermal macrophages (dMphs) are resident APCs closely related to blood 
monocytes, similarly to inflammatory DCs present in cutaneous autoimmune conditions. All skin 
APCs capture glycosylated proteins via C-type lectins, and anti-lectin antibodies have been used to 
specifically convey antigens to APC subsets. We propose here a novel targeting approach based on 
recombinant viral envelope proteins. Indeed, arboviruses are naturally inoculated into the skin by 
insect bites and have a specific glycosylation pattern which is recognized by lectins. Recombinant 
soluble envelope protein 2 of Chikungunya virus (CHIK-sE2) was produced in the S2 insect cell 
line. Surface plasmon resonance showed a high affinity of CHIK-sE2 for lectins DC-SIGN/CD209 
and Macrophage Mannose Receptor/CD206, which are expressed by CD14+ dDCs and dMphs. 
To evaluate its targeting of skin APCs, CHIK-sE2 was coupled to a fluorochrome and incubated 
with APCs isolated from healthy human skin explants. CHIK-sE2 exclusively bound to CD14+ 
dDCs and dMphs, but not to LCs and CD1a+ dDCs. As a model for inflammatory skin DCs, human 
monocyte-derived DCs were also targeted by CHIK-sE2. Finally, we tracked the internalisation of 
fluorescent CHIK-sE2 into intracellular compartments of targeted cells by confocal microscopy. 
Based on these results, we are currently developing functional assays to further validate CHIK-sE2 
as an efficient targeting agent for the delivery of antigens and bioactive molecules to monocytic 
dermal APCs in healthy and inflammatory skin.    
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GATA3 regulates filaggrin expression in human keratinocytes during inflammatory conditions
J Zeitvogel, N Jokmin, S Rieker and T Werfel Division for Immunodermatology and Allergy 
Research, Clinic for Dermatology, Allergy and Venereology, Hannover Medical School, 
Hannover, Germany
GATA3 is a transcription factor with a putative important role in atopic dermatitis since it is involved 
in the differentiation of Th2 lymphocytes. However, GATA3 is not exclusively expressed by T cells 
but also amongst others by keratinocytes. In contrast to T cells the role of GATA3 in keratinocytes 
is still poorly explored, especially in regard to inflammatory skin diseases like atopic dermatitis 
and psoriasis. Thus, it was the aim of this study to investigate the role of GATA3 in keratinocytes 
under different inflammatory conditions. For this purpose we silenced GATA3 in human primary 
keratinocytes by lentiviral transduction and analysed the expression of several genes important for 
the epidermal barrier such as involucrin, loricrin, filaggrin, and filaggrin 2. We could detect that 
a downregulation of GATA3 leads to a reduced expression of involucrin, loricrin, filaggrin and 
filaggrin 2. Furthermore, we found that these effects of GATA3 were dependent on the current micro 
milieu: A significant reduction of filaggrin was only present in GATA3 silenced keratinocytes that 
were treated with IL-4/IL-13, whereas stimulation abrogated the effect on involucrin. Our results 
demonstrate that GATA3 is involved in the regulation of barrier proteins during inflammatory con-
ditions in the skin. Thus GATA3 is of special importance for the establishment and maintenance 
of an intact epidermal barrier.    
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Propionibacterium acnes produced propionic acid may contribute to the pathogenesis of 
acne vulgaris
G Tax,1 E Urban,2 Z Palotás,1 R Puskás,3 Z Kónya,3 T Bíró,4 L Kemény1 and K Szabo5 1 
Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary, 2 
Institute of Clinical Microbiology, University of Szeged, Szeged, Hungary, 3 Department of 
Applied and Environmental Chemistry, University of Szeged, Reaction Kinetics and Surface 
Chemistry Research Group of the Hungarian Academy of Sciences, Szeged, Hungary, 4 
Departments of Physiology and Immunology, Faculty of Medicine, University of Debrecen, 
DE-MTA “Lendület” Cellular Physiology Research Group, Debrecen, Hungary and 5 MTA-
SZTE Dermatological Research Group, Szeged, Hungary
Propionibacterium acnes (P. acnes) is an important member of the skin microbiome from puberty, 
especially in sebum rich skin regions. The bacterium can modify the cellular properties (cell growth, 
cytotoxicity) of keratinocytes, in which bacterially secreted end products of anaerobic fermentation 
may play a prominent role. In order to analyze this effect in detail, we measured the amount of ace-
tic- and propionic acid (AA, PA respectively) in the supernatant samples of P. acnes-treated human 
immortalized keratinocytes (HPV-KER cells) by mass spectrometry. We found that the quantity of 
secreted PA is strain- and dose dependent. Faster growing, pathogenic strains (889, ATCC11828) 
secreted more PA to their environment. As a result, they induced more pronounced pH changes 
and higher level of cytotoxicity in the surrounding HPV-KER cells, compared to a strain isolated 
from healthy skin samples (6609). We also performed fluorescent microscopic analysis of direct 
PA-treated keratinocytes and found cells exhibiting compromised morphology, similar to that we 
observed in case of high-dose P. acnes 889 and ATCC 11828 treatments. These results indicate that 
apart from possible roles in maintaining skin pH and providing energy source for human cells, PA 
may also exhibits deleterious effects when the local concentration rises due to excessive P. acnes 
bacterial growth and/or metabolism. The resulting tissue damage together with innate immune 
activation may contribute to the pathogenesis of acne vulgaris.    
439
Relation between Psoriasis and obesity
D Herbert, K Stelzner and A Saalbach Dermatology, Allergology and Venerology, Universal 
Hospital Leipzig, Leipzig, Germany
Obesity and Psoriasis (PSO) are common diseases in today’s population with an increasing prev-
alence. PSO is an (auto)immune/inflammatory skin disease characterized by thickening of the 
epidermis, parakeratosis, elongated rete ridges, and a mixed cellular infiltrate consisting mainly of 
dendritic cells (DC), T cells (TC) and macrophages in the dermis and neutrophils and some TCs in 
the epidermis. There is a known correlation between severity of psoriatic disease and body mass 
index (BMI), but at present it is unclear how obesity is involved mechanistically in the pathogenesis 
of psoriatic inflammation. To investigate the relationship between obesity and the manifestation of 
PSO mice were fattened with a high-fat diet and a human PSO-like mouse-model was established 
using the TLR7 agonist Imiquimod (IMQ). These obese mice and ob/ob mice, too, showed a dra-
matically worse PSO than lean ones. H&E staining were performed and epidermis thickness was 
measured. The psoriatic skin of obese mice showed an increased epidermis thickening compared 
to lean mice. Further, gene expression analysis of the affected skin was done by qPCR. It could be 
shown that pro-inflammatory cytokines, like IL-23 and IL-17, were more increased in obese than 
in lean mice. It is known that free fatty acid (FFA) levels are increased during obesity. Performing 
co-cultures of DCs with FFAs or DCs with supernatants of FFA-co-cultured fibroblasts it was shown 
that IL-23 production of DCs and IL-17 production of TCs could be increased by oleic and palmitic 
acid. Consequently, high concentrations of these mediators in obese IMQ-mice and PSO patients 
seem to be a possible explantion for a worse severity of psoriatic symptoms.    
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Vitiligo is enriched with population of skin T cells expressing a resident memory phenotype
K Boniface, B Dessarthe, C Vernisse, N Boukhedouni, D Thiolat, A Darrigade, A Bertolotti, 
A Taieb, K Ezzedine and J Seneschal Dermatology, Bordeaux University, Bordeaux, France
Vitiligo is a chronic auto-immune depigmenting skin disorder, characterized by significant CD4+ and 
CD8+ T-cell infiltration. After repigmentation, vitiligo frequently recurs in the same area, suggesting 
the concept of skin memory disease. Indeed, it was recently shown that human healthy skin is 
protected by distinct populations of resident and recirculating memory T cells. Moreover, resident 
memory T cells (TRM) are involved in the pathogenesis of cutaneous inflammatory and autoimmune 
disorders such as psoriasis. Therefore, we thought to investigate the frequency of resident and 
recirculating memory T cells in human vitiligo. We carefully extracted T cells from healthy controls 
skin and peri-lesional skin from vitiligo patients. Flow cytometry analysis demonstrated increased 
frequency of non-recirculating CCR7- CD69+ skin TRM cells in vitiligo with relatively small fraction 
of recirculating CCR7+ memory T cells, compared to healthy skin. The majority of vitiligo CD8+ 
non-recirculating T cells beared CD103 marker together with CD69, compared to the CD4+ T cell 
subset. By immunofluorescence study, we could readily demonstrate that CD8+ TRM are located 
in the epidermis and dermis, while CD4+ TRM are mainly found in the upper-dermis. Interestingly, 
peri-lesional skin taken from patients with chronic and stable disease, showed increased frequencies 
of TRM compared to healthy skin cells suggesting that these TRM cells can promote vitiligo flare-up 
after local stimulation. Furthermore, skin TRM from vitiligo patient’s displayed effector functions as 
shown by their pro-inflammatory cytokine secretion profile. These findings support the hypothesis 
that vitiligo could be considered as a skin memory inflammatory disorder.    
441
Topical treatment with ivermectin inhibits acute models of skin inflammation
F Weltzer,1 C Pascau,1 B Montpellier,1 M Schuppli-Nollet,1 P Rossio,1 A Jomard,1 
M Vocanson,2 V Julia Barbero,1 E Vial1 and F Hacini-Rachinel1 1 Research, Galderma R&D, 
Biot, France and 2 U1111,CIRI, Lyon, France
Subtype 2 Papulopustular Rosacea (PRR) is a common facial skin disease, characterized by erythema 
and transient papules and pustules. While PRR physiopathology remains poorly characterized, 
recent findings suggest a Demodex-associated immune response and an abnormal innate immune 
response. Interestingly, Phase III trials with ivermectin (IVM) 1% cream have demonstrated a robust 
efficacy for IVM in treating the inflammatory skin lesions of PRR. This drug has been widely used as 
an anti-parasitic agent, however whether its beneficial effect in PRR management could also involve 
anti-inflammatory properties remains to be elucidated. To this aim, we evaluated the effect of IVM in 
several acute models of skin inflammation. Topical IVM treatment dose-dependently inhibited both 
12-O-tetradecanoylphorbol-13-acetate (TPA)-, arachidonic acid (AA)- induced skin inflammation. 
Since TPA-induced skin inflammation involves a rapid release of prostaglandins, leukotrienes, and 
inflammatory cytokines as well as neutrophil recruitment, which are some features of PRR, we 
focused on this model to further investigate the protective effect of IVM. Topical treatment with 0.3% 
IVM decreased ear swelling and this inhibition was fully achieved at 1%, as did topical reference 
corticosteroid). This effect was associated with (i) decreased amounts of several pro-inflammatory 
cytokines in skin. At the cellular level, (ii) in a 80% decreased in the absolute number of neutrophils 
as well as in the inflammatory monocytes. In addition, topical combination of IVM with Brimonidine, 
an approved drug for Subtype 1 erythematoteleangiectatic rosacea, greatly potentiates the reduction 
of ear edema. Taken together, these data demonstrate the potent anti-inflammatory effects of IVM 
in acute skin inflammation and further suggest that combination of IVM and Brimonidine could be 
of interest to manage all skin Rosacea subtypes.    
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DNA-cathelicidin complexes: vehicles assisting macrophage host defense against 
mycobacteria?
A Stephan, J Steiger and M Fabri Department of Dermatology, University of Cologne, 
Cologne, Germany
In response to infectious threats neutrophils secrete cathelicidin antimicrobial peptide, either free 
or - as part of neutrophil extracellular traps (NETs) - in complex with DNA. We previously pre-
sented that NET-derived DNA-cathelicidin complexes were internalized by macrophages, and that 
NET-associated cathelicidin localized in lysosomal compartments. However, whether NET-associ-
ated internalized cathelicidin attacks intracellular mycobacteria and assists macrophage mediated 
killing of mycobacteria remains unknown. Here, we show that DNA-cathelicidin complexes are 
internalized by mycobacteria-infected primary human macrophages and co-localize with bacteria 
in lysosomal compartments using four color confocal microscopy. Furthermore, chloroquine treat-
ment resulted in lysosomal accumulation of DNA, whereas in untreated cells internalized DNA 
was observed primarily in the cytosol indicating that cathelicidin is released from bound DNA. In 
addition, we investigated whether DNA from DNA-cathelicidin complexes activates macrophage 
defense pathways. qPCR analysis showed an upregulation of host defense pathway genes, such as the 
antimicrobial peptide DEFB4, upon stimulation of macrophages with DNA-cathelicidin complexes, 
but not with cathelicidin alone. Taken together, our data point to a dual function of cathelicidin-DNA 
complexes in promoting macrophage host defense against mycobacteria: First, direct killing of 
bacteria via cathelicidin and second, DNA-mediated activation of the macrophage host defense.   
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Psoriasis associated changes in the cutaneous microbiome
E Langan,1 A Kunstner,2 D Thaci,3 D Zillikens,2 S Ibrahim,2 W Solbach1 and J Knobloch1 1 
Institute of Medical Microbiology and Hygiene, University of Luebeck, Luebeck, Germany, 
2 Institute of Experimental Dermatology, University of Luebeck, Luebeck, Germany and 3 
Comprehensive Centre for Inflammation Medicine, University of Luebeck, Luebeck, Germany
The extent to which the cutaneous microbiome is altered in chronic inflammatory skin diseases, 
including psoriasis, remains unclear. Skin swabs/washings were obtained from the retro-auricular 
crease, upper back and umbilicus. Lesional and non-lesional skin in patients with plaque-type 
psoriasis (n=14, mean age 51 +/- 12.2 years, PASI 5.1 +/- 3.9, 5 females (F), 9 males (M)) was also 
swabbed and compared to site-matched swabs in healthy controls (n=9, mean age 38 +/- 11.2 
years, 6F and 3M). 16S ribosomal PCR and next generation sequencing was used to identify the 
microbiome composition. High throughput bacterial identification for culturable bacteria (cultu-
rome) with MALDI-TOF spectrometry was also performed in these and 6 additional plaque-type 
psoriasis patients (mean age 51 +/- 9.3 years, PASI 8.2 +/- 10.8, 1F and 5M). Systemic antibiotic 
use prior to study participation was an exclusion criterion. Although Firmicutes were the most 
prevalent bacterial phyla identified from both healthy skin and psoriatic lesional skin, the percentage 
was significantly increased in psoriatic lesional skin (54 % versus 94 %, p<0.05). In contrast, the 
proportion of the Phyla Actinobacteria was significantly increased in healthy skin when compared 
to psoriatic lesional skin (43% versus 6%, p<0.05). These patterns were consistent with the findings 
form the sequencing data. Capscale analysis revealed significant differences for both skin site and 
lesional versus non-lesional skin using the Jaccard and Bray-Curtis dissimilarity indices (p<0.05). In 
addition, bacterial alpha diversity was decreased at most skin sites in patients with psoriasis when 
compared to healthy controls. These data confirm significant shifts in the bacterial flora associated 
with psoriasis, with a tendency to a decrease in bacterial biodiversity. Future studies will address 
whether the changes are persistent and/or influenced by systemic treatment.    
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The psoriasis-associated cytokine interleukin-17 inhibits Langerhans’ cell migration in healthy 
human epidermis
LH Eaton, RJ Dearman, I Kimber and CE Griffiths The University of Manchester, Manchester, 
United Kingdom
Psoriasis is an immune-mediated inflammatory disease affecting approximately 2% of the Euro-
pean population. It is associated with increased expression of the cytokines interleukin (IL)-17 and 
IL-23 and antibody therapy directed towards either cytokine is effective. Langerhans’ cells (LC) are 
dendritic cells of the epidermis that regulate the cutaneous immune response. We have shown 
previously that LC migration is impaired in the uninvolved skin of patients with chronic plaque 
psoriasis. The aim was to investigate the role of IL-17 and IL-23 in the regulation of LC mobilisation. 
Five healthy volunteers with no history of skin conditions (4 male, 1 female mean age 35y) provided 
four 6 mm punch biopsies, under local anaesthetic, from sun-protected buttock skin. Epidermal 
sheets were isolated and one was fixed immediately (T0). The other three were floated on medium 
containing 100 ng/ml IL-17, 100 ng/ml IL-23, or the equivalent amount of bovine serum albumin 
(BSA) vehicle control for 24h (T24) before fixing. The frequency of epidermal LC was assessed and 
migration was calculated as the percentage loss of LC in the T24 compared with the T0 epidermal 
sheet. Incubation with BSA vehicle control resulted in a significant reduction in LC frequency in 
the T24 compared with the T0 sample (p < 0.0001). The same was true for IL-23 treatment (p = 
0.0028). In contrast, epidermal sheets cultured with IL-17 for 24h displayed no significant change 
in LC frequency compared with the T0 control. The mean percentage migration in the BSA and 
IL-23 sheets was 14.6±1.0% and 17.4±5.1%, respectively (the proportion of LC that are able to be 
mobilised rapidly is consistent with previous observations) and significantly higher than the level 
of migration with IL-17 (0.9±1.7%). Thus, in healthy epidermis, IL-17, but not IL-23, impairs LC 
migration. We propose that overexpression of IL-17 in uninvolved psoriasis skin provides a potential 
mechanism for the impairment of LC migration in psoriasis.    
445
Glucocorticoids dissociate anti-mycobacterial pathways in human macrophages
J Steiger,1 A Stephan,1 P Kroell,1 MS Inkeles,3 S Stenger,4 B Brachvogel,2 M Pellegrini,5 
RL Modlin3 and M Fabri1 1 Department of Dermatology, University of Cologne, Cologne, 
Cologne, Germany, 2 Center for Biochemistry, University of Cologne, Cologne, Germany, 
3 Division of Dermatology, David Geffen School of Medicine at University of California 
Los Angeles (UCLA), Los Angeles, CA, 4 Institute for Medical Microbiology and Hygiene, 
University Hospital of Ulm, Ulm, Germany and 5 Department of Molecular, Cell, and 
Developmental Biology, UCLA, Los Angeles, CA
Chronic intake of glucocorticoids (GCs) increases the risk to develope active mycobacterial disease; 
however, when used as adjuvant in combination with antibiotics, GCs reduce extensive tissue dam-
age in established infections. Nevertheless, the effect of GCs on innate immunity against intracellular 
mycobacteria is unclear. Here, we investigated the direct effect of GCs on anti-mycobacterial host 
defense programs in primary human macrophages. We found that GCs triggered the expression 
of cathelicidin, a critical effector in the macrophage anti-mycobacterial response. GC induction 
of cathelicidin was independent of intracellular vitamin D metabolism, a known mechanism to 
upregulate cathelicidin expression in human macrophages. However, despite cathelicidin induction, 
GCs failed to promote anti-mycobacterial activity, suggesting that GCs either fail to activate or even 
suppress other critical factors of the macrophage defense response. Weighted gene coexpression 
network analysis of GC- and IFN-γ-stimulated macrophages was used to screen for such factors. We 
identified components of vacuolar H+-ATPases, which are responsible for acidification of bacterial 
phagolysosomes, as potential candidates. Using qPCR, FACS, immunofluorescence and confocal 
microscopy we demonstrated that the inability of GCs to promote anti-mycobacterial activity was 
linked to a failure to induce expression and phagolysosome recruitment of vacuolar H+-ATPases. 
Taken together, our study shows that GCs partially activate anti-mycobacterial pathways in human 
macrophages and identifies vacuolar H+-ATPases as potential targets for host-directed therapies 
against intracellular infection in GC-treated patients.    
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HLA-II epitope prediction for the Candida albicans proteome revealed important aspects of 
adaptive anticandidal immunity
M Manczinger, V Bodnar, L Lakatos and L Kemény Department of Dermatology and 
Allergology, University of Szeged, Szeged, Hungary
The role of innate immunity in human–Candida albicans interactions has already been investigated 
in detail; nonetheless, our knowledge about the role of adaptive anticandidal immunity in these 
interactions is limited. We used a human leukocyte antigen (HLA) II epitope prediction approach, 
consensus, to scan the entire proteome of C. albicans. We also developed an analysis pipeline 
based on strict statistical significance for processing prediction results. Our results suggest that 
adaptive immune recognition has a fundamental role in the differentiation between pathogenic and 
non-pathogenic forms of C. albicans and that proteins as well as protein domains related to patho-
genesis and filamentous growth carry the most HLA-II epitopes. Surprisingly, common HLA alleles 
recognize fewer epitopes in the C. albicans proteome than uncommon ones. However, recognition 
by common alleles is more specific for protein function, as ATP-binding cassette transporters are 
recognized only by common alleles. Phylogenetic analysis based on epitope similarity identified 
two genera that share numerous epitope sequences with C. albicans, Eimeria and Drosophila; 
further investigation is needed to explain this phenomenon. Furthermore, our results suggested 
markedly different mechanism of immune recognition for Candida glabrata. Our results allowed 
us to infer several interesting general aspects of HLA-II immune recognition, including issues of 
domain-preference of epitopes and the impact of gene expression on the encoded protein domain 
antigenicity. Our results will contribute to the understanding of fundamental phenomena describing 
the role of adaptive immunity in the host–pathogen interaction. The fact that our computational 
results support experimental results in numerous cases indicate that the assumptions made for the 
calculations are valid.    
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Regulation of the expression of the B7 family molecules in melanoma cells
E Tjin,1 K Willemsen,1 G Krebbers,1 C Melief,2 F Vyth-Dreese3 and RM Luiten1 1 
Dermatology, Academic Medical Center, Amsterdam, Netherlands, 2 ISA pharmaceuticals, 
Leiden, Netherlands and 3 Immunology, The Netherlands Cancer Institute-Antoni van 
Leeuwenhoek Hospital, Amsterdam, Netherlands
The balance between costimulatory and inhibitory B7 family molecules expressed on melanoma 
cells may be decisive for T-cell activation. Costimulatory molecules (e.g. CD40, CD80, CD86) play a 
crucial role in inducing a potent immune responses, while the inhibitory B7 family molecules PDL-1 
(B7-H1) and PDL-2 (B7-DC) negatively regulate T-cells responses and are commonly depicted as 
immune evasion mechanism for tumors. PDL-1 expression in tumors correlates with unfavorable 
prognosis for many human cancers. Recent studies show the therapeutic potential of agents tar-
geting PD-1 or its ligand PDL-1 in patients with advanced cancer. Durable and clinical responses 
were measured in these patients with various tumor types. Since PDL-1 expression on tumor cells 
is strongly upregulated by IFNγ, it is important to investigate which stimuli can (up)regulate the 
expression of inhibitory molecules on tumor cells. Conversely, modulation of costimulatory mol-
ecule expression on tumor cells can be used to enhance tumor-specific T-cell responses in cancer 
patients and can be considered as an alternative therapeutic approach. Here, we found that PD-1 
and its ligands PDL-1 and -2 are expressed in metastatic melanoma tissues. PDL-1 expression on 
human melanoma cell lines (n=8) was strongly induced by IFNγ. Addition of IFNα, IL-4 and IL-10 
resulted in PDL-1 upregulation, dependent on the cell density of the melanoma cells, while no effect 
was measured with IL-2, IL-6, IL-15 or TGF3b. In contrast to PDL-1, PDL-2 expression was not or 
slightly influenced by these cytokines. Expression of the costimulatory molecules CD40, CD80, 
CD86 or HLA-DR was mainly induced by IFNγ but differential effects with the other cytokines were 
also observed. Our results suggest that (proinflammatory) cytokines can influence the expression of 
costimulatory and/or inhibitiory molecules on melanoma cells and can be relevant for treatment of 
melanoma and potential therapeutic strategy.    
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Human dermal fibroblasts as regulators of human monocyte differentiation and macrophage 
activity during inflammation
RA Ferrer, I Forstreuter, JC Simon and S Franz Department of Dermatology, Venerology and 
Allergology, University Leipzig, Leipzig, Germany
Cells of mesenchymal lineage are important regulators of tissue homeostasis and repair. Upon 
damage multipotent mesenchymal stromal cells (MSC) support inflammation and contribute to 
inflammatory resolution by secreting pro-inflammatory and immunoregulatory mediators at the same 
time. Dermal fibroblasts (DF) represent cells of mesenchymal lineage in adult skin. Whether DF exert 
immunomodulatory effects upon inflammation, specifically on monocyte (Mon) differentiation into 
macrophages (Mac) remains unknown and was the aim of this study. We performed co-cultures of 
human Mon with either bone marrow derived MSC or DF. Characterizing the cells by flow cytometry 
and analyzing co-culture supernatants by ELISA revealed that both cells types are equipotent in 
influencing Mon differentiation and Mac activity. Peripheral blood derived CD14+Mon that were 
pushed with GM-CSF to differentiate into M1-Mac phenotypes in co-culture with either MSC of DF 
resulted in Mac characterized by reduced release of inflammatory TNF and IL-12p40 and abundant 
secretion of pro-resolution IL-10. This secretory profile suggests that Mon have differentiated towards 
M2 immunomodulating Mac in the presence of MSC or DF although they have been stimulated 
with a M1 polarizing cytokine. Analyzing cell surface markers of the differentiated Mac confirmed 
a M2 phenotype with increased expression of CD206 and CD163. To assess the mechanisms of 
DF-mediated immunoregulation in situations of acute inflammation DF were stimulated with early 
pro-inflammatory TNF and IL-1b resulting in increased expression of Cox-2, responsible for PGE2 
synthesis, and TSG-6. Both mediators are key regulators of MSC involved in their polarizing activity 
on Mon and Mac. Interestingly, CD14+Mon differentiation into M1-Mac was also shifted towards M2 
phenotypes by supernatants of DF activated with TNF-α/IL-1β. Our results suggest that DF perform 
crucial immunoregulatory functions in the skin by controlling important events of inflammatory 
resolution upon tissue damage.    
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Natural Cytotoxicity Receptor Positive Group 3 Innate Lymphoid Cells as Biomarker of 
Treatment Response in Psoriasis
M Teunissen, S Menting and PI Spuls Dermatology, Academic Medical Center, Amsterdam, 
Netherlands
Innate lymphoid cells (ILC) are currently regarded as important regulators of tissue homeostasis and 
inflammation. Lineage negative (Lin−) ILC are present in healthy human skin and mainly comprises 
CRTH2+ group 2 ILC (ILC2) and CD117+ natural cytotoxicity receptor NKp44 negative (NCR−) ILC3, 
as well as a small proportion of CD117−NCR−CRTH2−CD161+ ILC1, and hardly any CD117+NCR+ 
ILC3. However, this latter population can develop from NCR− ILC3 upon culture in the presence 
of IL-1β plus IL-23, cytokines known to be involved in psoriatic inflammation. Remarkably, sig-
nificantly increased proportions of NCR+ ILC3 are present in lesional skin and peripheral blood 
of psoriasis patients as compared to skin and blood of healthy individuals. Considering the many 
alternatives in therapy for psoriasis and the diversity of individual treatment responses, the quest for 
biomarkers indicative of the treatment response outcome is warranted. In this study we questioned 
whether ILC3 could serve as a biomarker. We examined the presence and frequency of ILC3 in 
peripheral blood of psoriasis patients at baseline and during regular therapy with Dovobet or anti-
TNF-α antibody Remicade (infliximab). The clinical disease activity as indicated by the psoriasis 
area severity index (PASI) was measured each time blood samples were taken. We found that the 
frequency of NCR+ ILC3 in the circulation declined during successful therapy in parallel with the 
decrease in PASI scores. Strikingly, no gross change in frequency of NCR+ ILC3 was found in case 
no clinical improvement was observed. Our data suggest that the frequency of NCR+ ILC3 in blood 
might serve as a biomarker reflecting the treatment response to therapy.    
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Tumor-associated macrophages and stromal factors play roles in developing mycosis fun-
goides in the different stages
S Furudate, T Fujimura, A Kakizaki, Y Kambayashi and S Aiba Department of dermatology, 
Tohoku university graduate school of medicine, Sendai, Japan
Mycosis fungoides (MF) starts as an indolent disease that progresses from a patch stage to confluent 
plaques, and finally develops skin tumors and shows visceral involvement. Recently, several reports 
suggested that immunosuppressive tumor-associated macrophages (TAMs) play roles in maintaining 
the tumor microenvironment in MF. The purpose of this study was to elucidate the involvement of 
TAMs in the lesional skin of different stages (10 cases of patchy, 10 cases of plaque and 5 cases of 
tumor stages) of MF. First, we immunohistologically examined the ratio of CD163+ macrophages and 
CD206+ cells, as well as periostin and IL-4 in cancer stroma. The ratio of CD206, which is known 
as a marker for M2 macrophages, was increased in parallel with the tumor stage, while there was 
no significant difference in the ratio of CD163. Interestingly, periostin was prominent in the stromal 
area in the patch and plaque stage but decreased in the tumor stage. In contrast, IL-4 was prominent 
in plaque and tumor stages. To further elucidate the molecular mechanisms of the effects of these 
stromal factors on TAMs, we examined their effects on mRNA expression in monocyte-derived 
macrophage in vitro. Using a microarray and gene ontology, we examined the series of chemokines 
and matrix metalloproteinases that were strongly connected with the periostin stimulation. Among 
them, we identified the upregulation of CCL7, CCL13, CCL17, CCL22, CXCL5, CXCL6 and CXCL10 
genes and MMP2, MMP7 and MMP12 genes. The DNA microarray results were verified using real-
time PCR. We further examined these chemokines and MMPs mRNA in the presence of periostin 
and IL-4 in order to analyze the later stages of MF. Our present report suggests one of the possible 
roles of TAMs in establishing the tumor microenvironment in MF.    
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Biomarkers to optimize ustekinumab therapy in psoriatic patients
E De Keyser,1 E Coussens,1 E Botti,3 L Meuleman,2 M Van De Kerckhove,5 H Boonen,4 
A Costanzo3 and J Lambert1 1 Dermatology, Ghent University, Ghent, Belgium, 2 Private 
Dermatology Practice, Lede, Belgium, 3 Dermatology, Sapienza University, Rome, Italy, 
4 Dermatology, H. Hart Hospital, Mol, Belgium and 5 Private Dermatology Practice, 
Maldegem, Belgium
We investigated the role of three potential biomarkers (ustekinumab serum levels, anti-drug anti-
bodies [ADAs] and HLA-Cw6 status) for optimizing ustekinumab treatment in psoriatic patients. A 
multicenter cross-sectional study, including 63 psoriatic patients treated with ustekinumab (≥ 16 
weeks), was performed. Serum samples were collected at 4 weeks and 12 weeks (serum through 
level [STL]) after a random injection of ustekinumab to measure the drug serum level (ELISA) and to 
detect ADAs (antigen-binding test). HLA-Cw6 status was determined by PCR. The Psoriasis Area and 
Severity Index (PASI) was calculated and clinical response was expressed as ΔPASI (% improvement 
of baseline PASI). Mean serum levels (STL and serum level at week 4) were respectively 0,43 μg/
ml (±0,34) and 2,91 μg/ml (±1,20). No correlation was found between STL and ΔPASI (rS=-0,015; 
p=0,908), nor between serum level at week 4 and ΔPASI (rS=-0,050; p=0,731). Only 1/63 patients 
developed ADAs. Twenty-five out of 61 patients (41 %) were HLA-Cw6 positive. There was a slight 
tendency toward a better ΔPASI in the HLA-Cw6 positive group. However, this was not statistically 
significant. In this study, we could not identify any biomarker that is significantly associated with 
clinical response to ustekinumab therapy in psoriatic patients. Remarkably, there was a very low 
prevalence of ADA (1,6 %). In particular, in an earlier study we described much higher prevalence 
of ADA against adalimumab in a similar population, using a similar assay (Menting et al, JAMA 
Dermatol, 2015). Further research is needed in order to investigate the particular immunogenic 
characteristics of ustekinumab and its complex pharmacokinetics, and to elucidate the potential 
role of gene polymorphisms in predicting response to ustekinumab.    
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PUVA leads to reduced inflammation in the imiquimod model of psoriasis
N Shirsath,1 G Mayer,1 J Ober,2 N Schweintzger1 and P Wolf1 1 Research Unit of 
Photodermatology, Department of Dermatology and Venereology, Medical University of 
Graz, Graz, Austria and 2 Center for Medical Research, Medical University of Graz, Graz, 
Austria
Psoriasis is a chronic inflammatory skin disease where cells of innate and adaptive immune system 
are relevant players in initiation and progression of disease. Here, we investigate the therapeutic 
effects of 8-methoxypsoralen plus UVA (PUVA) on key mediators in the initiation and progression 
phase of psoriasis using the imiquimod (IMQ) psoriasis mouse model and the effect of the treatment 
on immune cell activation. In study protocol 1, BALB/c mice were treated daily for 5 days with a 
topical dose of 82 mg of commercially available IMQ cream (Aldara 5% creamTM) and (simulta-
neously) exposed to a subphototoxic dose of 0.25 J/cm2 or a near-phototoxic dose of 0.50 J/cm2 
twice per week for 2 weeks. In addition, in study protocol 2 mice were pretreated with topical 
PUVA twice a week for 2 weeks with a gap of 2 days (group 2) and a prolonged gap of 8 days to 
start of IMQ treatment (group 3), while to the control mice IMQ was applied only (group 1). Skin, 
blood, spleen and lymph nodes were collected at day 16 for analysis. In PUVA pretreated mice 
(group 2) there was significantly reduced inflammation up to a 70%, as measured by macroscopic 
skin swelling (p < 0.05) and epidermal thickness (p < 0.001) compared to control. This observation 
was linked with significant and marked reduction of spleen size (p=0.0002), as well as dendritic 
cells (CD11C+), pDC (120G8+), macrophages (F4/80+), and B cells (B220+) and T cells (CD4+ 
and CD8+) in spleen and lymph nodes. PUVA also lowered numbers of neutrophiles (p=0.04) and 
monocytes (p=0.059) in the blood. The effect of PUVA was lost when a prolonged gap of 8 days to 
start of IMQ treatment was applied (group 3). Taken together, this data shows that PUVA reduces 
imiquimod-induced inflammation. The fact that pretreatment of PUVA is effective in the model 
points to an indirect therapeutic mechanism related to affection of immune cells in particular of 
innate immunity.    
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Delayed-Type Hypersensitivity Induced by FITC in Mice: Pharmacological Modulation with 
Dexamethasone, Tacrolimus and Tofacitinib.
M Pont, A Garrido, N Crespo, C Balagué, N Prats, J Molín, M Aulí, A Domènech and 
N Godessart Dermatology Research Department, Almirall S.A., Sant Feliu Llobregat, Spain
We aimed at exploring the impact of drugs with different mechanisms of action on the delayed-type 
hypersensitivity (DTH) model induced by FITC in mice. For this purpose, a corticosteroid (dexa-
methasone), a calcineurin inhibitor (tacrolimus) and a JAK inhibitor (tofacitinib) were tested using 
different routes and administration regimen protocols. For induction, FITC was applied to both ears 
of BALB/c mice on days 1- 2. On day 8, FITC was applied to the right ear (challenge) and 24 h later, 
ear punch biopsies were taken to determine oedema and histological changes. Test compounds were 
administered orally (1-100 mg/kg) or topically (1-100 μg) during the sensitisation phase (days 1-5) or 
at the challenge (day 8). In vehicle-treated animals ear swelling was accompanied by a mixed dermal 
cellular infiltrate, epidermal pustules and mild hyperplasia. The three tested drugs showed different 
efficacy profiles following their topical application. Tofacitinib (60 μg) demonstrated efficacy only 
when administered during the sensitisation phase (63% inhibition). Tacrolimus (20 μg) inhibited 
ear swelling in both regimens, but with a higher efficacy following treatment during sensitisation 
than at challenge (96% versus 46% inhibition). In contrast, dexamethasone (1 μg) suppressed ear 
oedema only at challenge (88% inhibition). By oral route tacrolimus and dexamethasone showed 
similar profile than by topical route, however high doses were needed for efficacy. The effect on ear 
swelling was associated with improvement in histological parameters. Our results show that in the 
FITC-induced DTH model, drugs are more efficacious by topical than by oral route, irrespective of 
their mechanism of action, suggesting that effector cells migrate to the skin during sensitisation and 
are activated in situ during challenge. For the evaluation of novel drugs, the efficacy results in the 
different administration regimens may provide clues on their main mode of action.    
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IL-37 – a protective cytokine in psoriasis?
A Langkilde, L Raaby, KF Hjuler, C Johansen and L Iversen Department of Dermatology, 
Aarhus University, Aarhus, Denmark
A number of co-morbidities of psoriasis have recently been recognized. Epidemiologic studies doc-
ument more than 50% increase in risks of diabetes, hypertension and obesity in psoriatic patients. 
Interleukin-37 (IL-37) has been described as a fundamental inhibitor of innate immunity by shifting 
the cytokine balance away from excessive inflammation. Furthermore, IL-37 was demonstrated to 
restore the immunological misbalance in obesity by counteracting adipocyte differentiation, adipose 
tissue inflammation and insulin resistance. Interestingly, IL-37 has also been shown to play an 
essential immunosuppressive role in the pathogenesis of psoriasis in vitro and in vivo. We intended 
to analyse IL-37 expression in the skin of psoriatic patients before and during treatment targeting 
TNF-alpha or IL-12/IL-23. A GeneChip array analysis (analysing 30000 genes) of excision biopsies 
from 9 psoriatic patients demonstrated that IL-37 was the most significantly (adj. p< 0.005) down 
regulated gene in lesional psoriatic skin compared with non-lesional skin. This was confirmed by 
qPCR performed on punch biopsies from 10 psoriatic patients treated with adalimumab, 13 psoriatic 
patients treated with ustekinumab (7 responders and 6 non-responders) and 6 healthy controls. We 
found IL-37 to be significantly higher expressed in healthy controls and non-lesional skin compared 
with lesional skin. IL-37 expression increased over time after treatment and reached a significantly 
higher expression level compared with day zero in patients responding to adalimumab and in 
patients responding to ustekinumab treatment - but not in the non-responding patients. Furthermore, 
ELISA performed on keratome biopsies from psoriatic patients confirmed that the IL-37 protein level 
was significantly higher in non-lesional skin compared with lesional skin. In conclusion we have 
demonstrated IL-37 to be the most down-regulated gene in lesional psoriatic skin compared with 
non-lesional skin among 30000 genes. Because of the known effects of IL-37 we suggest that it may 
be an important link between psoriasis, obesity and insulin resistance.    
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The role of orphan receptor Interleukin-17 Receptor D in the pathogenesis of psoriasis.
M Mellett,1 F Truzzi,2 PN Moynagh,3 C Pincelli,2 E Contassot1 and LE French1 1 Department 
of Dermatology, University Hospital Zurich, Zurich, Switzerland, 2 University of Modena and 
Reggio Emilia, Modena, Italy and 3 Biology Department, Maynooth University, Maynooth, 
Ireland
Interleukin 17 Receptor D (IL-17RD), also known as Similar expression to FGF genes (SEF), is an 
orphan receptor of the IL-17 receptor family, having no known ligand. We previously reported 
that IL-17RD differentially regulates IL-17A signalling pathways by directly targeting IL-17 receptor 
adaptor protein, Act1, by SEF / IL-17R (SEFIR)/SEFIR interactions, which leads to downregulation 
of NF-κB and ERK activation but increased p38 MAPK activity. This makes IL-17RD a potential 
target for developing therapeutics for disease where IL-17 signalling is implicated, including pso-
riasis. Indeed, two separate single nucleotide polymorphisms in the Il17rd gene have recently 
been linked to an augmented risk of Crohn’s disease and increased psoriasis susceptibility. Il17rd 
gene expression has also been shown to be down-regulated in psoriatic lesions. Therefore, it is of 
interest to characterise a role for IL-17RD in psoriasis pathogenesis. Here we demonstrate that the 
regulatory effects of IL-17RD are not restricted to IL-17 signalling but IL-17RD also targets Toll-
like receptor-induced signalling pathways. In primary human peripheral blood mononuclear cells 
(PBMCs), knockdown of Il17rd mRNA levels leads to enhanced pro-inflammatory signalling and 
gene expression. IL-17RD-deficient mice were also more susceptible to TLR-induced septic shock 
and pro-inflammatory cytokine-induced inflammation. We assessed IL-17RD protein expression 
in psoriatic tissue by immunohistochemistry staining and observed decreased IL-17RD protein 
expression in the epidermis of psoriasis patients compared to controls. Interestingly, this loss of 
Il17rd expression also correlated with higher expression of pro-inflammatory molecules. Taken 
together our data suggest that IL-17RD is an important regulator of the pro-inflammatory pathways 
that contribute to psoriasis pathogenesis.    
456
Unraveling leukocyte populations in adipose tissue
R Naito,1 M Brüggen,1 W Bauer,1 M Zeyda,3 F Koszik,1 H Kiprov2 and G Stingl1 1 Dept. 
Dermatol., DIAID, Medical University of Vienna, Vienna, Austria, 2 Private Clinic Kiprov, 
Vienna, Austria and 3 Dept. Internal Medicine III, Medical University of Vienna, Vienna, 
Austria
Adipose tissue (AT) had long been regarded as a site of inert lipid/energy storage. More recent 
evidence exists that AT can be both source and target of various inflammatory cytokines and 
adipokines. In order to determine the potential cellular source(s) of such mediators, we sought to 
immunophenotypically characterize the leukocytic infiltrate of AT. Therefore, we collected AT from 
abdominoplasty surgeries as well as from liposuctions. Multicolor immunofluorescence stainings 
of tissue sections and flow cytometry of isolated cells were used to characterize residing immune 
cell populations in AT. For FACS, cells were obtained from AT specimens using a collagenase I 
digestion followed by a Ficoll gradient. Our FACS analyses revealed that 70% of the isolated cells 
were stromal cells, i.e. fibroblasts, endothelial cells and preadipocytes. The remaining 30% were 
leukocytes (defined by the expression of CD45). CD3 positive T lymphocytes constituted about 
20% of the overall leukocyte population. On AT tissue sections, these CD3+ T cells were mostly 
located in the interlobular AT septa. The vast majority of T cells expressed the memory T cell 
marker CD45RO, whereas only 2% showed a naive T cell phenotype (CD45RA). Interestingly, 
20-30% of CD3+CD45RO+ T cells expressed the skin homing marker, CLA. In contrast to T cells, 
B cells (CD19+) were virtually absent. 60% of CD45+ cells expressed CD14. The majority of these 
macrophages expressed the ‘M2’ marker CD206 . Mast cells, basophils, NK cells as well as other 
innate lymphoid cell populations were also present. In conclusion, our data revealed a prominent 
leukocytic infiltrate in AT and constitute the basis for next exploring the inflammatory processes in 
AT of chronic inflammatory diseases such as obesity and psoriasis.    
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Ex vivo and in vivo studies support safety and non-invasiveness of hair follicle targeting for 
transcutaneous immunization strategies
A Vogt,1 S Hadam,1 E Pfannes,1 B Combadiere2 and U Blume-Peytavi1 1 Department 
of Dermatology, Charite-Universitaetsmedizin Berlin, Berlin, Germany and 2 Centre 
d’Immunologie et des Maladies Infectieuses, Université Pierre et Marie Curie, INSERM U543, 
Paris, France
Non-invasive targeting of cutaneous antigen-presenting cells does not only offer practical advan-
tages. Our previous clinical trials with transcutaneously (t.c.) administered influenza vaccine using 
a skin surface method which targets hair follicles (CSSS) indicate, that while rather poor in induc-
tion of humoral responses, t.c. immunization may be helpful for the induction of cytotoxic T cell 
responses. In ex vivo studies, CSSS removed only 30% of stratum corneum material, but activated 
Langerhans cells and significantly increased the penetration of 200nm polystyrene particles deep 
into hair follicles. In this in vivo study in 12 volunteers, we assessed skin barrier function and 
integrity after CSSS compared to conventional adhesive tape stripping. We found no indication for 
marked inflammation within the first 48 hrs after the procedure assessed by clinical examination 
and presence of inflammatory cytokines (IL1aplha, IL-6 or IL-8) in skin surface material. TEWL 
values were markedly increased shortly after CSSS and adhesive tape which dropped quickly after 
the procedures. Return to baseline was slightly delayed in CSSS-treated areas. In accordance to 
the larger amount of stratum corneum removed by CSSS we observed stronger decreased pH 
values in CSSS treated skin areas slowly recovering over time compared to tape-stripped skin. No 
changes in skin elasticity was observed. Volunteers indicated in the questionnaires that they would 
readily choose CSSS-based TC vaccination as vaccination method if available. These observations 
make CSSS a highly interesting technology for patch immunizations, because the size of viruses, 
virus-like-particles, and nanocarriers favours hair follicle penetration, because immune activation 
enhances uptake activity, and because we previously found hair follicles to be key sites for cellular 
uptake of carriers and candidate vaccines.    
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IFNg/IL-17 cytokine milieu is characteristic of papulopustular rosacea
G Béke,1 Z Dajnoki,1 G Mócsai,1 A Kapitány,1 K Gáspár,1 K Hajdu,1 D Töröcsik,2 
I Kovács,3 T Bíró4 and A Szegedi1 1 Division of Dermatological Allergology, Department 
of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 2 
Department of Dermatology, Debrecen, Hungary, 3 Department of Pathology, Debrecen, 
Hungary and 4 Departments of Immunology and Physiology, Debrecen, Hungary
Rosacea is a common chronic inflammatory skin condition typically occurring on sebaceous gland 
rich (SGR) skin areas; its pathophysiology is quite complex and poorly understood. We sought to 
investigate and compare the innate and adaptive immune cell components and cytokine profile of 
papulopustular rosacea (PPR) and SGR skin. 10 PPR and 10 healthy SGR skin biopsies were gained 
which were used for immunohistochemistry to detect CD3+ / CD4+ T cells, CD11c+ dermal myeloid 
DCs, CD1a+ Langerhans cells, CD163+ / Factor XIII+ macrophages. Immunostaining of cytokines 
mainly but not exclusively characteristic of T cells, namely IL-10, IL-13, IL-17 and IFNg was also 
carried out. May-Grünwald-Giemsa (MGG) routine staining was also performed to compare the 
number of eosinophils, neutrophils and mast cells. Cell counts were quantified by Pannoramic 
Viewer software. Biopsies were also used to measure IL-10, IL-13, IL-17 and IFNg gene expression 
by qPCR. In PPR samples infiltrating DCs, T cells and macrophages were detected in significantly 
higher numbers compared to SGR skin. The number of Langerhans cells showed no difference. 
MGG staining revealed that several neutrophils were present in PPR samples, but similar to SGR skin 
eosinophils were missing. Cell count of mast cells was elevated compared to SGR skin. Cytokine 
milieu of PPR skin represented significantly elevated number of IL-10+ and IL-17+ cells compared 
to SGR skin samples and strong IFNg positivity also turned up. The gene expression pattern of the 
cytokines corresponded to our results on protein levels. In conclusion inflammatory IFNg/IL-17 
cytokine milieu could be a crucial factor in the pathogenesis of PPR.    
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An insight into the expression patterns of antimicrobial peptides psoriasin, RNase7, HBD-2,-3 
and LL37 in polymorphic light eruption.
V Patra,1 G Mayer,1 U Schmidbauer,2 A Gruber-Wackernagel,1 M Horn2 and P Wolf1 1 
Research Unit for Photodermatology, Medical University of Graz, Graz, Austria and 2 
Department of Dermatology, Medical University of Graz, Graz, Austria
Polymorphic light eruption (PLE) is a common photodermatosis that has been linked to immuno-
logical abnormalities. Previous work of normal skin of PLE patients has indicated that there is an 
abnormal regulation of antimicrobial peptides (AMPs) to UV exposure that may be involved in the 
pathogenesis of the disease (Felton S et al, Photochem Photobiol Sci 2013; 12(1):29-36). AMPs are 
best known in fighting against a wide range of gram-negative and gram-positive bacteria, as well as 
fungi and few viruses. Recent studies indicate that AMPs not only act against microorganisms, but 
also are actively involved in adaptive immune responses and can modulate immune reactions. Our 
study focuses on AMPs in lesional skin of PLE. We performed immunohistochemistry for psoriasin, 
RNase7, HBD-2, -3 and LL-37 on tissue sections of archived, paraffin-embedded skin samples from 
PLE lesions (n=5-12) and compared the results to that from samples (n=5-13) of sun-exposed or 
not-exposed adjacent healthy skin available from surgical excision of various skin tumours. Intensity 
of staining and/or number of positive cells were quantified by semi-quantitative scores. We observed 
significant expression of psoriasin, RNase7, HBD-2 and reduced expression of HBD-3 in PLE lesions 
compared to the healthy skin. Interestingly, LL-37 was highly expressed around blood vessels and 
sweat glands in PLE lesions but not in healthy skin. The expression patterns observed could be due 
to UV exposure, which is known to upregulate certain AMPs. Since these AMPs are known to have 
immunomodulating properties, our observations of differentially expressed AMPs suggest that they 
may indeed play a role in the pathophysiology of PLE.    
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Mast cells are increased in intrinsically aged skin and are inversely related to Langerhans 
cell numbers
SM Pilkington,1 S Abdu,1 RE Watson,2 RJ Dearman,1 I Kimber1 and CE Griffiths2 1 Faculty 
of Life Sciences, University of Manchester, Manchester, United Kingdom and 2 Faculty of 
Medical and Human Sciences, University of Manchester, Manchester, United Kingdom
Aged skin exhibits a functional decline in immunity, associated with increased susceptibility to 
infection and malignancy, alongside an increased inflammatory status. A reduced number of antigen 
presenting cells, Langerhans cells (LC), is thought to contribute to these effects, but little is known 
about changes in other cutaneous immune cell populations during ageing. This study aimed to 
assess differences in leukocyte populations between young and aged skin. Skin biopsies from 
photoprotected buttock skin of six young (median age 26yrs; range 23-29yrs) and five aged (75yrs; 
75-77 years) White Caucasians were taken and immunostaining performed on skin sections to 
identify neutrophils (elastase), macrophage (CD68), mast cells (tryptase), LC (CD1a), CD4+ and 
CD8+ T cells. Cells were enumerated by light microscopy and were mainly localised to the dermis, 
except for LC which were present in dermis and epidermis. No differences in macrophage and 
CD4+ T cell numbers were observed between young and aged skin, whereas CD8+ T cell numbers 
appeared higher in aged compared with young skin (mean (± SEM) of 22.6 ± 6.3 cells/high power 
field (hpf) vs 13.4 ± 2.9; not significant). Mast cell numbers were higher in aged compared with 
young skin (50 ± 4.8 cells/ hpf vs 25 ± 2.8 cells/hpf; p<0.01); total LC numbers were lower in aged 
compared with young skin (18 ± 1.0 cells/hpf vs 31 ± 5.8 cells/hpf; p<0.05). Moreover, mast cell 
numbers were found to correlate inversely with LC numbers (r=-0.86; p<0.05), while no correlations 
were observed between LC and the other skin resident immune populations. Intrinsically aged skin 
exhibits alterations in leukocyte populations which may contribute to declining immune function. A 
reduction in LC number may be associated with diminished regulatory control of immune responses 
and could contribute to elevated numbers of cutaneous inflammatory cells such as mast cells. Further 
studies in larger subject groups are warranted.    
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Polymorphonuclear granulocytes from individual donors carry a distinct predisposition to 
undergo NETosis: Application of a refined method for extracellular trap quantification
J Hoffmann, K Schäkel, A Enk and E Hadaschik Dermatology, University of Heidelberg, 
Heidelberg, Germany
Neutrophil extracellular trap (NET) formation is a recently discovered mechanism of innate immune 
defense by which polymorphonuclear granulocytes (PMN) produce net-like structures of decon-
densed chromatin strands decorated with antimicrobial peptides to trap microorganisms. If this 
process leads to cell death it is termed “NETosis”. Alterations of this mechanism were reported to 
be involved in the pathogenesis of autoimmune diseases including psoriasis and systemic lupus 
erythematosus. The available methods to quantify NETosis ex vivo and in vitro are problematic, as 
they do not reliably preserve the delicate morphology of NETs, do not differentiate between viable 
and dead cells, do not differentiate between modes of cell death, or require expensive automatized 
setups or software. We report and test a refined semi-automated method for NET quantification 
that does not require extensive processing of cells or expensive dyes and can be easily performed 
in most laboratory settings. The results of the semi-automated procedure were in good agreement 
with manual counting, were robust against perturbations in the method, and were reproducible in 
repeated measurements. Interestingly, the response of PMN from different healthy individuals to 
Phorbol myristate acetate (PMA) stimulation was remarkably heterogeneous and considerably con-
stant over time, suggesting a distinct predisposition of PMN from individual donors for NETosis. Our 
results and the related methods can help investigators to reliably quantify NETosis in various settings.   
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Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft-versus-host Disease
F Chasset,1 H Le Buanec,2 F Sicre de Fontbrune,3 A de Masson,1 J Rivet,4 A Bergeron,5 
M Bagot,1 G Socié,3 A Bensussan2 and J Bouaziz1 1 Dermatology, Saint Louis Hospital, 
Paris, France, 2 Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells,, 
INSERM and UMRS 976, Paris, France, 3 Hematology and Transplantation, Saint Louis 
Hospital, Paris, France, 4 Pathology Department, Saint Louis Hospital, Paris, France and 5 
Pneumology Department, Saint Louis Hospital, Paris, France
We describe a case of psoriasiform chronic graft-versus-host Disease (cGVHD) and investigated 
the Th1/Th17/Tr1 cytokine secretion profile of the skin infiltrate. A 47-year-old man with relapsed 
acute lymphoid leukemia had haematopoietic stem cell transplantation (HSCT) from unrelated 
9/10 human leucocyte antigen matched donor. One year after HSCT, he developed moderate 
lung cGVHD and severe skin cGVHD consistent with psoriasis. The pathological examination 
demonstrated characteristic findings of both psoriasis and cGVHD. 5mm skin punch biopsy was 
taken and cultured in complete medium with recombinant interleukin 2 (60 Units/ml). After nine 
days, cells were activated during 5 hours with phorbol-myristate-acetate and ionomycin together 
with brefeldin plus Monensin added during the 4 last hours of culture. Seven-color cell surface 
and intracellular flow cytometry staining were performed. We found a predominant proportion 
of IFN-γ (Th1) CD4+ T cells (50.87%) and to a lesser extent IL-17 producing (Th17) CD4+ T-cells 
(4.93%), comprising double positive CD4+IFN-γ +IL-17+T cells (2.1%). In addition, we found both 
IFN-γ single producing CD8+ T cells (86.5%)and IL-17 positive CD8+ T cells (4.3%)consisting for 
most of them double positive CD8+IFN-γ +IL-17+ T cells (3.7%). IL-10 producing CD4+ or CD8+ T 
cells were almost absent Overall the cytokine profile was similar with those described in psoriasis. 
These results encourage us to investigate more extensively the CD4+ and CD8+ T cells cytokine 
profile in the different clinical forms of skin cGVHD which could give a rationale to use new 
biotherapies in skin cGVHD.    
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Innate immunity of keratinocytes in rosacea
I Khamaganova,1 N Potekaev,2 O Svitich,3 L Gankovskaya3 and O Novozhilova4 1 
department of skin diseases & cosmetology, Pirogov Russian national research medical 
university, Moscow, Russian Federation, 2 Health Department, Moscow, Russian Federation, 
3 department of immunology, Pirogov Russian national research medical university, Moscow, 
Russian Federation and 4 Moscow scientific & practical centre for dermatovenerology & 
cosmetology, Moscow, Russian Federation
Rosacea is a common inflammatory facial skin disease characterised by erythema,teleangiectasia,-
papules and pustules.Dysfunctional cutaneous vasculature and neuronal dysregulation seem to be 
driving forces in rosacea pathophysiology.The complex activation of the innate immune system 
may enhance neurovascular changes.The objective of the study was analysis of indicators of innate 
immunity of the keratinocytes in patients with rosacea and in healthy persons.35 patients aged 21 to 
72 years old,including 8 men,27 women and 6 healthy subjects aged 30-39 years were examined.
Total RNA was isolated from keratinocytes and combined with random primers and reverse primers 
for the target genes.The real time PCR was performed for quantitative analysis. The median of Toll- 
like receptor2(TLR2) was significantly reduced in the affected skin to 3856 and in healthy skin in 
rosacea patients to 2627 in comparison with healthy subjects(16126).The median of the expression 
of human beta defensin 1(hBD1) was significantly reduced in the affected skin to 28318 and in 
healthy skin in rosacea patients to 24732 in comparison with healthy subjects(79252).The median 
of the expression of human beta defensin 2(hBD2) was significantly reduced in the effective skin to 
2267 and in healthy skin in rosacea patients to 1990 in comparison with healthy subjects (24626).
The study shows significant decrease of innate immunity in rosacea skin.    
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Evaluation of BCG scars and PPD response after BCG vaccination in 4 year old children
R Ghaderi Birjand University of Medical Science, Birjand, Iran (the Islamic Republic of)
Tuberculosis is an important health problem in developing countries and the BCG vaccine plays 
an important role in preventing the disease. The rates of positive tuberculin skin test (TST) reactions 
and BCG scarring after BCG vaccination vary between studies and populations. This study was done 
for evaluating of BCG scars and PPD response after BCG vaccination in 4 year old children. In this 
cross sectional descriptive analytical study, 120 children had been enrolled. First, we measured 
BCG scars diameters and then 0.1 milliliter of standard 10 unit Purified protein derivative (PPD) 
solution was injected intradermally. After 72 hours, biggest indurations diameters were measured. 
Data were analyzed by using SPSS package version 19, Chi Square and logistic regression analysis 
tests. 54 cases of total 120 cases were male and 66 cases were female. 38 cases (32%) had not 
any BCG scar and PPD test was negative in this cases. PPD test indurations diameters were lesser 
than 3 millimeters in 57 cases (48%) and BCG scars diameters were lesser than 2 millimeters in 
67cases (56%). The mean of BCG scars diameters were 1.95 millimeters in male cases and 1.46 
millimeters in female cases. Mean of PPD test indurations diameters were 4.5 millimeters in male 
cases and 3.6 millimeters in female cases. According to the results there is a significant positive 
relationship between PPD test indurations diameters and BCG scars diameters. According to the PPD 
test indurations diameter formula (PPD test induration diameter = 1.5 + 1.5 × BCG scar diameter), 
we can anticipate PPD test indurations according to BCG scar diameter in 4 year old children.   
      
